{"count":59,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=S.+2658&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/7fc22c44-b171-4709-a0af-5da6e5cf51f5/","filing_uuid":"7fc22c44-b171-4709-a0af-5da6e5cf51f5","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/7fc22c44-b171-4709-a0af-5da6e5cf51f5/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jennifer Holmes","dt_posted":"2026-04-17T09:33:02-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"418 C St NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":400774330,"url":"https://lda.gov/api/v1/registrants/400774330/","house_registrant_id":null,"name":"S-3 GROUP","description":"Government consulting firm","address_1":"418 C St NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER HOLMES","contact_telephone":"+1 202-819-5036","dt_updated":"2026-07-25T19:32:13.062375-04:00"},"client":{"id":64053,"url":"https://lda.gov/api/v1/clients/64053/","client_id":64053,"name":"FRESENIUS KABI","general_description":"Healthcare/pharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148207,"prefix":null,"prefix_display":null,"first_name":"KRISTI","nickname":null,"middle_name":null,"last_name":"REMINGTON","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148207,"prefix":null,"prefix_display":null,"first_name":"KRISTI","nickname":null,"middle_name":null,"last_name":"REMINGTON","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7fc22c44-b171-4709-a0af-5da6e5cf51f5/","filing_uuid":"7fc22c44-b171-4709-a0af-5da6e5cf51f5","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/7fc22c44-b171-4709-a0af-5da6e5cf51f5/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jennifer Holmes","dt_posted":"2026-04-17T09:33:02-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"418 C St NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":400774330,"url":"https://lda.gov/api/v1/registrants/400774330/","house_registrant_id":null,"name":"S-3 GROUP","description":"Government consulting firm","address_1":"418 C St NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER HOLMES","contact_telephone":"+1 202-819-5036","dt_updated":"2026-07-25T19:32:13.062375-04:00"},"client":{"id":64053,"url":"https://lda.gov/api/v1/clients/64053/","client_id":64053,"name":"FRESENIUS KABI","general_description":"Healthcare/pharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148207,"prefix":null,"prefix_display":null,"first_name":"KRISTI","nickname":null,"middle_name":null,"last_name":"REMINGTON","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148207,"prefix":null,"prefix_display":null,"first_name":"KRISTI","nickname":null,"middle_name":null,"last_name":"REMINGTON","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5e947cad-7bb7-4291-bb48-85856b0c8c27/","filing_uuid":"5e947cad-7bb7-4291-bb48-85856b0c8c27","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/5e947cad-7bb7-4291-bb48-85856b0c8c27/print/","filing_document_content_type":"text/html","income":null,"expenses":"3830000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Nancy LeaMond, Chief Advocacy and Engagement Officer","dt_posted":"2026-04-20T12:52:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 E STREET, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20049","registrant":{"id":1694,"url":"https://lda.gov/api/v1/registrants/1694/","house_registrant_id":30636,"name":"AARP","description":null,"address_1":"601 E Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20049","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KELSY M. BENNETT","contact_telephone":"+1 202-434-2379","dt_updated":"2026-07-30T21:42:41.965444-04:00"},"client":{"id":102643,"url":"https://lda.gov/api/v1/clients/102643/","client_id":12,"name":"AARP","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-23"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S.2120, the Older Americans Act Reauthorization Act. H.R. 5575, the Firefighters Assisting Seniors to Emergency Response (FASTER) Act. S. 668/H.R. 3183, Supporting Access to Falls Education and Prevention and Strengthening Training Efforts and Promoting Safety Initiatives (SAFE STEPS) for Veterans Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed minimum staffing standards. No bill number. Discussed Nursing Home staffing standards, safety, and quality. No bill number. Discussed Nursing home transparency and ownership requirements. No bill number. Discussed health technology, data security, and access. No bill number. Discussed senior nutrition and food security programs. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed falls prevention. No bill number. Discussed social isolation. No bill number. Discussed enhanced premium tax credits for health insurance. No bill number. Discussed artificial intelligence in clinical care. No bill number. Discussed Health Data, Technology, and Interoperability (HTI-5) Proposed Rule. No bill number. Discussed Affordable Care Act Benefit and Payment Parameters. No bill number. Discussed electronic notification by health insurance plans. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed Medicaid HCBS. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number Discussed direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce. No bill number. Discussed end-of-life. No bill number. Discussed health savings accounts. No bill number. Discussed prescription drugs. No bill number. Discussed health care workforce issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102859,"prefix":null,"prefix_display":null,"first_name":"GLEN","nickname":null,"middle_name":null,"last_name":"FEWKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66615,"prefix":null,"prefix_display":null,"first_name":"BRENDAN","nickname":null,"middle_name":"K","last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":56692,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SCHOLNICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143384,"prefix":null,"prefix_display":null,"first_name":"GIDGET","nickname":null,"middle_name":null,"last_name":"BENITEZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54508,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"HISHTA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102859,"prefix":null,"prefix_display":null,"first_name":"GLEN","nickname":null,"middle_name":null,"last_name":"FEWKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48421,"prefix":null,"prefix_display":null,"first_name":"LEIGH","nickname":null,"middle_name":null,"last_name":"PURVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":56692,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SCHOLNICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66615,"prefix":null,"prefix_display":null,"first_name":"BRENDAN","nickname":null,"middle_name":"K","last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143384,"prefix":null,"prefix_display":null,"first_name":"GIDGET","nickname":null,"middle_name":null,"last_name":"BENITEZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102859,"prefix":null,"prefix_display":null,"first_name":"GLEN","nickname":null,"middle_name":null,"last_name":"FEWKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143384,"prefix":null,"prefix_display":null,"first_name":"GIDGET","nickname":null,"middle_name":null,"last_name":"BENITEZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48421,"prefix":null,"prefix_display":null,"first_name":"LEIGH","nickname":null,"middle_name":null,"last_name":"PURVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":56692,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SCHOLNICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66615,"prefix":null,"prefix_display":null,"first_name":"BRENDAN","nickname":null,"middle_name":"K","last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TRA","general_issue_code_display":"Transportation","description":"No bill number. Discussed Surface Transportation Reauthorization. No bill number. Discussed information collection supporting the Fatality Analysis Reporting System (FARS). No bill number. Discussed vehicle safety and design for road safety. No bill number. Discussed roadway design and safety. No bill number. Discussed transportation access for older adults.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143386,"prefix":null,"prefix_display":null,"first_name":"CORALETTE","nickname":null,"middle_name":null,"last_name":"HANNON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FAM","general_issue_code_display":"Family issues/Abortion/Adoption","description":"S. 925/H.R. 2036, Credit for Caring Act. S. 1565/H.R. 138, Lowering Costs for Caregivers Act. S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, One Big Beautiful Bill Act. S. 830/H.R. 2560, the Lifespan Respite Care Reauthorization Act. H.R. 3089, the More Paid Leave for More Americans Act. H.R. 8100, the Safe Staffing Saves Lives Act. S. 3886, the Nurses Belong in Nursing Homes Act. H.R. 6766/S. 3492, the Essential Caregivers Act of 2025. H.R. 7966/S. 4118, the Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act S.2120, the Older Americans Act Reauthorization Act of 2025. H.R. 5575, the Firefighters Assisting Seniors to Emergency Response (FASTER) Act of 2025. H.R. 7567, the Farm, Food, and National Security Act of 2026. HR 1538, the Delivering for Rural Seniors Act of 2025. H.R. 1782, the Supporting all Healthy Options when Purchasing Produce (SHOPP) Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed paid leave for family caregivers. No bill number. Discussed support for family caregivers. No bill number. Discussed minimum staffing standards for long-term care facilities. No bill number. Discussed the Senior Hunger Prevention Act. No bill number. Discussed Nursing Home staffing standards, safety, and quality. No bill number. Discussed Nursing home transparency and ownership requirements. No bill number. Discussed SNAP, TEFAP, OAA nutrition programs, senior nutrition and food security. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed falls prevention. No bill number. Discussed social isolation. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed fraud in Medicare and Medicaid, long-term services and supports, and home and community-based services. No bill number. Discussed research and data on family caregivers. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce. No bill number. Discussed end-of-life. No bill number. Discussed Assisting Caregivers Today (ACT) Caucus. No bill number. Discussed long-term care affordability. No bill number. Discussed long-term care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102859,"prefix":null,"prefix_display":null,"first_name":"GLEN","nickname":null,"middle_name":null,"last_name":"FEWKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":110336,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BIGLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66615,"prefix":null,"prefix_display":null,"first_name":"BRENDAN","nickname":null,"middle_name":"K","last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":56692,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SCHOLNICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151632,"prefix":null,"prefix_display":null,"first_name":"ELISA","nickname":null,"middle_name":null,"last_name":"WALKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 925/H.R. 2036, the Credit for Caring Act. S. 1565/H.R. 138, the Lowering Costs for Caregivers Act. Public Law 119-21, the One, Big, Beautiful Bill Act. S. 1831, Auto Reenroll Act. S. 1840, the Retirement Investment in Small Employers Act. S. 1773/ H.R. 3469, the Tax Relief for Victims of Crimes, Scams, and Disasters Act. H.R. 2972, the EITC for Older Workers Act. H.R. 1340, the More Homes on the Market Act. HR. 1130, the Bonus Tax Relief for Americas Seniors Act. No bill number. Discussed paper tax refund checks. No bill number. Discussed advance premium tax credit for Marketplace health plans. No bill number. Discussed family caregiver tax credit bill. No bill number. Discussed health savings accounts. No bill number. Discussed tax policy. No bill number. Discussed retirement policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":110336,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BIGLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102859,"prefix":null,"prefix_display":null,"first_name":"GLEN","nickname":null,"middle_name":null,"last_name":"FEWKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66615,"prefix":null,"prefix_display":null,"first_name":"BRENDAN","nickname":null,"middle_name":"K","last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151632,"prefix":null,"prefix_display":null,"first_name":"ELISA","nickname":null,"middle_name":null,"last_name":"WALKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"H.R. 5514, the Protect Older Job Applicants Act (POJA Act). H.R. 5115 / S. 2703, the Protecting Older Americans Act. H.R. 3522/ S. 1820, the Protecting Older Workers Against Discrimination Act. H.R. 7917, Fair Wages for Home Care Workers Act. S.2120, the Older Americans Act Reauthorization Act.. H.R. 3089, the More Paid Leave for More Americans Act. No bill number. Discussed prohibiting employers from asking age-related questions during the hiring process. No bill number. Discussed the Workforce Innovation and Opportunity Act. No bill number. Discussed Senior Community Service Employment Program. No bill number. Discussed employment programs for older workers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":110336,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BIGLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FIN","general_issue_code_display":"Financial Institutions/Investments/Securities","description":"S. 4055/H.R. 1469, the Senior Security Act. S.4092, the No Crypto in Social Security Act. H.R. 6644, the ROAD to Housing Act. S. 2117/H.R. 1734, the Preventing Deep Fake Scams Act. S. 2840/H.R. 2478, the Financial Exploitation Prevention Act. S. 1467/H.R. 2808, the Homebuyers Privacy Protection Act. H.R. 2978, the GUARD Act. S. 4144/H.R. 306, the Ending Scam Credit Repair Act (ESCRA) Act. S.1773/H.R. 3469, the Tax Relief for Victims of Crimes, Scams, and Disasters Act. S. 2019/H.R. 4936, the Taskforce for Recognizing and Averting Payment Scams (TRAPS) Act. H.R. 3633, the Digital Asset Market Clarity Act. H.R. 6425, the National Strategy for Combating Scams Act. H.R. 7215, the Stop SCAMS Act. S.1877/H.R.2441, the Improving Disclosure for Investors Act. H.R.2988, the Protecting Prudent Investment of Retirement Savings Act. S. 1699, Artificial Intelligence Public Awareness and Education Campaign Act. No bill number. Discussed accredited investor issues. No bill number. Discussed fiduciary obligations. No bill number. Discussed investor protections. No bill number. Discussed veterans and scams. No bill number. Discussed Social Security and crypto investments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151632,"prefix":null,"prefix_display":null,"first_name":"ELISA","nickname":null,"middle_name":null,"last_name":"WALKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"RET","general_issue_code_display":"Retirement","description":"S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. Public Law 119-21, the One, Big, Beautiful Bill Act. S.1831 Auto Reenroll Act. H.R.6722 Automatic IRA Act. S. 1526/H.R. 2696, the Retirement Savings for Americans Act. S.1840, the RISE Act. S.3924, the We Cant Wait Act. S.4255, the Expedited Disability Insurance Payments for Terminally Ill Individuals Act. H.R.3517, the Social Security Enhancement and Protection Act. S.4092, the No Crypto in Social Security Act. H.R.6644, the ROAD to Housing Act. S.988 /H.R. 2023, the Women's Retirement Protection Act. H.R.6084, the ERISA Litigation Reform Act. S.1234/HR 2540, the SSI Savings Penalty Elimination Act. S.1504/HR 5284, the Claiming Age Clarity Act. S. 1666/HR 5345, the Improving Social Securitys Service to Victims of Identity Theft Act. H.R. 5348, the Social Security Child Protection Act. H.R. 3695, the Social Security Access Act. H.R. 3271/S 1690, the Medicare & Social Security Fair Share Act. S. 4184, the Senior Citizens Freedom to Work Act. H.R. 1877, the Protecting Americans Social Security Data Act. S. 4001/HR 7828, the Supplemental Security Income Restoration Act. H.Res.1059 - Of inquiry requesting the President of the United States to furnish certain information to the House of Representatives relating to the Department of Government Efficiency's access to and usage of NUMIDENT and other personally identifiable information in the possession of the Social Security Administration. H.R. 7573, the Modernize SSI Stipends Act. No bill number. Discussed retirement access and coverage issues. No bill number. Discussed fiduciary obligations. No bill number. Discussed alternative assets in retirement plans. No bill number. Discussed Lifetime income. No bill number. Discussed retirement plan rollovers. No bill number. Discussed litigation reform and ERISA. No bill number. Discussed federal retirement savings program. No bill number. Discussed funding for the Social Security Administration (SSA). No bill number. Discussed SSAs customer service and agency operations. No bill number. Discussed SSAs in-person service options. No bill number. Discussed SSAs National Scheduling Calendar initiative. No bill number. Discussed SSAs engagement with advocacy groups. No bill number. Discussed Social Securitys Retirement Earnings Test. No bill number. Discussed Social Security solvency. No bill number. Discussed a balanced budget amendment. No bill number. Discussed SSA data privacy. No bill number. Discussed the Senior Independence Act. No bill number. Discussed the Final Month Fairness Act. No bill number. Discussed the Social Security Caregiver Credit Act. No bill number. Discussed Social Security and crypto investments. No bill number. Discussed a sovereign wealth fund for Social Security. No bill number. Discussed ways to improve SSI take-up.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":110336,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BIGLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151632,"prefix":null,"prefix_display":null,"first_name":"ELISA","nickname":null,"middle_name":null,"last_name":"WALKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":65,"name":"General Services Administration (GSA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"H.R. 5514, the Protect Older Job Applicants Act (POJA). H.R. 5115/ S. 2703, the Protecting Older Americans Act. H.R. 3522/ S. 1820, the Protecting Older Workers Against Discrimination Act. No bill number. Discussed prohibiting employers from asking age-related questions during the hiring process.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":110336,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":null,"last_name":"BIGLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 3290/ H.R. 5166, the Financial Services and General Government Appropriations Act. S. 2354/ H.R. 5342, the Commerce, Justice, Science, and Related Agencies Appropriations Act. S. 2587/ H.R. 5304, the Labor, HHS, Education and Related Agencies Appropriations Act. H.R.7148, the FY 26 Consolidated Appropriations Act. No bill number. Discussed funding for the Social Security Administration (SSA). No bill number. Discussed Senior Community Service Employment Program (SCSEP). No bill number. Discussed Social Security customer service report language. No bill number. Discussed funding for DOL workforce programs. No bill number. Discussed funding for OAA supported programs and other nutrition program. No bill number. Discussed the FBIs IC3 reporting systems. No bill number. Discussed international cooperation on fraud issues. No bill number. Discussed funding for coordinated government response on financial fraud. No bill number. Discussed state and local law enforcement and fraud investigations. No bill number. Discussed fraud and financial exploitation-related report language. No bill number. Discussed Low Income Home Energy Assistance Program (LIHEAP). No bill number. Discussed housing. No bill number. Discussed surface transportation reauthorization and related programs. No bill number. Discussed OAA nutrition programs. No bill number. Discussed support for family caregivers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143386,"prefix":null,"prefix_display":null,"first_name":"CORALETTE","nickname":null,"middle_name":null,"last_name":"HANNON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151632,"prefix":null,"prefix_display":null,"first_name":"ELISA","nickname":null,"middle_name":null,"last_name":"WALKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":150,"name":"Federal Bureau of Investigation (FBI)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"H.R. 6644, the 21st Century ROAD to Housing Act. H.R. 4957/S. 1260, the Rural Housing Service Reform Act. H.R. 5990/S. 127, the Whole-Home Repairs Act. H.R. 4576/S. 2363, the Build More Housing Near Transit Act. H.R. 1340/S. 3332, the More Homes on the Market Act. S. 3502, the Timeshare Pricing Transparency Act. H.R. 5575, Firefighters Assisting Seniors To Emergency Response (FASTER) Act. No bill number. Discussed the Reforming Disaster Recovery Act. No bill number. Discussed housing affordability. No bill number. Discussed housing supply. No bill number. Discussed housing accessibility.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143386,"prefix":null,"prefix_display":null,"first_name":"CORALETTE","nickname":null,"middle_name":null,"last_name":"HANNON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"S. 4144/H.R. 306, the Ending Scam Credit Repair Act (ESCRA) Act. S. 1467/H.R. 2808, the Homebuyers Privacy Protection Act. S. 3982/H.R. 7786, the AI Fraud Accountability Act. S. 1699, Artificial Intelligence Public Awareness and Education Campaign Act. S. 314/ H.R. 1479, the Hotel Fees Transparency Act. S. 3354 /H.R. 1027, the QUIET Act. S. 3774/H.R. 7548, SCAM Act. S. 281/ H.R. 1402, the TICKET Act. H.R. 6678, the Senior Legal Hotline Act. S. 2120, the Older Americans Act (OAA) Reauthorization Act. No bill number. Discussed veterans and scams.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102859,"prefix":null,"prefix_display":null,"first_name":"GLEN","nickname":null,"middle_name":null,"last_name":"FEWKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143386,"prefix":null,"prefix_display":null,"first_name":"CORALETTE","nickname":null,"middle_name":null,"last_name":"HANNON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"S. 3354 /H.R. 1027, the QUIET Act. S. 2840/H.R. 2478, Financial Exploitation Prevention Act. No bill number. Discussed AI-powered robocalls, robotexts, and fraud. No bill number. Discussed robocall mitigation and fraud prevention. No bill number. Discussed telecommunications, network resiliency, and network modernization. No bill number. Discussed Universal Service Fund reform. No bill number. Discussed the Broadband Equity Access and Deployment (BEAD) program. No bill number. Discussed digital skills and broadband affordability. No bill number. Discussed Next Generation 911. No bill number. Discussed truth-in-billing protections. No bill number. Discussed broadband label rules.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143386,"prefix":null,"prefix_display":null,"first_name":"CORALETTE","nickname":null,"middle_name":null,"last_name":"HANNON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":53,"name":"Federal Communications Commission (FCC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":112,"name":"Natl Telecommunications & Information Administration (NTIA)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DIS","general_issue_code_display":"Disaster Planning/Emergencies","description":"S. 1773/H.R. 3469, the Tax Relief for Victims of Crimes, Scams, and Disasters Act. H.R. 5575, the Firefighters Assisting Seniors To Emergency Response (FASTER) Act. No bill number. Discussed disaster planning and response for older adults.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143386,"prefix":null,"prefix_display":null,"first_name":"CORALETTE","nickname":null,"middle_name":null,"last_name":"HANNON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":56692,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"SCHOLNICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102859,"prefix":null,"prefix_display":null,"first_name":"GLEN","nickname":null,"middle_name":null,"last_name":"FEWKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"P.L. 119-21, One Big Beautiful Bill Act. H.R. 7567, the Farm, Food, and National Security Act. HR 1538, the Delivering for Rural Seniors Act. H.R. 1782, the Supporting all Healthy Options when Purchasing Produce (SHOPP) Act. No bill number. Discussed the Senior Hunger Prevention Act. No bill number. Discussed SNAP, TEFAP, OAA nutrition programs, senior nutrition and food security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102859,"prefix":null,"prefix_display":null,"first_name":"GLEN","nickname":null,"middle_name":null,"last_name":"FEWKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"S. 2117/H.R. 1734, Preventing Deep Fake Scams Act. H.R. 2978, the Guarding Unprotected Aging Retirees from Deception (GUARD) Act. H.R. 3774, the SCAM Act. H.R. 5490, Dismantle Foreign Scam Syndicates Act. H.R. 5967, Strategic Task Force on Scam Prevention Act. H.R. 6425, National Strategy for Combating Scams Act. H.R. 6426, STOP Scams Against Seniors Act. H.R. 7215, the Stop SCAMS Act. S. 2544, the Guarding Unprotected Aging Retirees from Deception (GUARD) Act. S. 2950, Scam Compound Accountability and Mobilization Act. S. 3355, National Strategy for Combating Scams Act. H.R. 6678, Senior Legal Hotline Act. S. 2683/H.R. 1663, the VSAFE Act. No bill number. Discussed fraud. No bill number. Discussed funding to improve the FBIs IC3 reporting systems. No bill number. Discussed funding to improve DOJs international cooperation on fraud issues. No bill number. Discussed financial fraud. No bill number. Discussed improvements to state and local fraud investigations. No bill number. Discussed veterans and scams. No bill number. Discussed fraud in Medicare and Medicaid.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42328,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"LEAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72084,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"SWEENEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143383,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55220,"prefix":null,"prefix_display":null,"first_name":"BEVERLY","nickname":null,"middle_name":null,"last_name":"GILYARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141057,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69977,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"KELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140338,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143385,"prefix":null,"prefix_display":null,"first_name":"APRIL","nickname":null,"middle_name":null,"last_name":"CANTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52001,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"SUMNER","last_name":"CUMMINGS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":71071,"prefix":null,"prefix_display":null,"first_name":"FERNANDO","nickname":null,"middle_name":null,"last_name":"RUIZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145092,"prefix":null,"prefix_display":null,"first_name":"CLARK","nickname":null,"middle_name":null,"last_name":"FLYNT-BARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143386,"prefix":null,"prefix_display":null,"first_name":"CORALETTE","nickname":null,"middle_name":null,"last_name":"HANNON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42329,"prefix":null,"prefix_display":null,"first_name":"RHONDA","nickname":null,"middle_name":null,"last_name":"RICHARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145091,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"RYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150711,"prefix":null,"prefix_display":null,"first_name":"NICOLE","nickname":null,"middle_name":null,"last_name":"DURITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150712,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"DONNELLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65677,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"O'REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":150,"name":"Federal Bureau of Investigation (FBI)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1418a58b-0775-4e45-9b77-06e8109c2656/","filing_uuid":"1418a58b-0775-4e45-9b77-06e8109c2656","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1418a58b-0775-4e45-9b77-06e8109c2656/print/","filing_document_content_type":"text/html","income":null,"expenses":"12210000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-04-20T13:06:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law No. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law No. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law No. 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No. 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Biopharmaceutical innovation policy issues SECURE Rx Act of 2026 (draft) User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1418a58b-0775-4e45-9b77-06e8109c2656/","filing_uuid":"1418a58b-0775-4e45-9b77-06e8109c2656","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1418a58b-0775-4e45-9b77-06e8109c2656/print/","filing_document_content_type":"text/html","income":null,"expenses":"12210000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-04-20T13:06:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law No. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law No. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law No. 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No. 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Biopharmaceutical innovation policy issues SECURE Rx Act of 2026 (draft) User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2c5d0123-1385-41b5-aa02-7303db5efcbf/","filing_uuid":"2c5d0123-1385-41b5-aa02-7303db5efcbf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2c5d0123-1385-41b5-aa02-7303db5efcbf/print/","filing_document_content_type":"text/html","income":null,"expenses":"1640000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-04-20T21:36:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (P.L. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75), Provisions related to the pharmaceutical industry. Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: H.R. 1492, Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025. To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Section 340B Public Health Services Act 340B engagement and MFN related engagement Provisions related to the 340B program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements Biopharmaceutical innovation and pricing issues HR 5509, Safe Step Act, Provisions related step therapy protocols Tariff and MFN issues VICP Bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2c5d0123-1385-41b5-aa02-7303db5efcbf/","filing_uuid":"2c5d0123-1385-41b5-aa02-7303db5efcbf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2c5d0123-1385-41b5-aa02-7303db5efcbf/print/","filing_document_content_type":"text/html","income":null,"expenses":"1640000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-04-20T21:36:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (P.L. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75), Provisions related to the pharmaceutical industry. Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: H.R. 1492, Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025. To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Section 340B Public Health Services Act 340B engagement and MFN related engagement Provisions related to the 340B program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements Biopharmaceutical innovation and pricing issues HR 5509, Safe Step Act, Provisions related step therapy protocols Tariff and MFN issues VICP Bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/dcd60574-b063-479a-829c-a06ed09e9219/","filing_uuid":"dcd60574-b063-479a-829c-a06ed09e9219","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/dcd60574-b063-479a-829c-a06ed09e9219/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Thomas Worrall, Partner","dt_posted":"2026-04-21T10:25:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 H Street, NW","registrant_address_2":"Suite 525","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":292892,"url":"https://lda.gov/api/v1/registrants/292892/","house_registrant_id":37346,"name":"WHITMER & WORRALL, LLC","description":"A government relations and consulting firm.","address_1":"1401 H Street, NW","address_2":"Suite 525","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARTIN WHITMER","contact_telephone":"+1 202-558-6000","dt_updated":"2026-07-22T13:56:32.152773-04:00"},"client":{"id":57911,"url":"https://lda.gov/api/v1/clients/57911/","client_id":57911,"name":"CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)","general_description":"Coalition to promote lowering prescription drug prices.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-11-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11986,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"WHITMER","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS-USDOT","new":false},{"lobbyist":{"id":16844,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"WORRALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144086,"prefix":null,"prefix_display":null,"first_name":"ERIK","nickname":null,"middle_name":null,"last_name":"KOMENDANT","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, Rep. Zoe Lofgren (CA); Legislative Director, Rep. Jason Altmire (PA); Policy Director, Blue Dog Coalition","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11986,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"WHITMER","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS-USDOT","new":false},{"lobbyist":{"id":16844,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"WORRALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144086,"prefix":null,"prefix_display":null,"first_name":"ERIK","nickname":null,"middle_name":null,"last_name":"KOMENDANT","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren; Policy Director, Blue Dog Coalition","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to prescription drug pricing. H.R. 5526 & S. 1954 Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 3014 Ensuring Timely Access to Generics Act of 2025 S. 1414 Expedited Access to Biosimilars Act S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.1262 Mikaela Naylon Give Kids a Chance Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11986,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"WHITMER","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS-USDOT","new":false},{"lobbyist":{"id":16844,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"WORRALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144086,"prefix":null,"prefix_display":null,"first_name":"ERIK","nickname":null,"middle_name":null,"last_name":"KOMENDANT","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, Rep. Zoe Lofgren (CA); Legislative Director, Rep. Jason Altmire (PA); Policy Director, Blue Dog Coalition","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 1785 & H.R. 3010, the No Handouts for Drug Advertisements Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11986,"prefix":null,"prefix_display":null,"first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"WHITMER","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS-USDOT","new":false},{"lobbyist":{"id":16844,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"WORRALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144086,"prefix":null,"prefix_display":null,"first_name":"ERIK","nickname":null,"middle_name":null,"last_name":"KOMENDANT","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, Rep. Zoe Lofgren (CA); Legislative Director, Rep. Jason Altmire (PA); Policy Director, Blue Dog Coalition","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cf79f5e7-d20d-450e-89d8-3cef7deb37c6/","filing_uuid":"cf79f5e7-d20d-450e-89d8-3cef7deb37c6","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cf79f5e7-d20d-450e-89d8-3cef7deb37c6/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David Kolbe","dt_posted":"2026-07-06T11:28:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1012 Apple Valley Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Howard","registrant_state":"OH","registrant_zip":"43028","registrant":{"id":401104329,"url":"https://lda.gov/api/v1/registrants/401104329/","house_registrant_id":null,"name":"DAVE KOLBE CONSULTING","description":"Veteran owned LLC.  Lobbying and other governmental labor management relations.","address_1":"1012 Apple Valley Drive","address_2":null,"address_3":null,"address_4":null,"city":"Howard","state":"OH","state_display":"Ohio","zip":"43028","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID KOLBE","contact_telephone":"+1 202-251-9701","dt_updated":"2026-07-06T10:34:03.198802-04:00"},"client":{"id":201535,"url":"https://lda.gov/api/v1/clients/201535/","client_id":24,"name":"PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION","general_description":"Pharmaceutical Industry Labor Management Association.","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-03-13"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"PROFITS OVER PATIENTS: THE PBM BUSINESS MODEL UNDER SCRUTINY\" - Support comprehensive reform that addresses the entire healthcare supply chain. PBM practices drive up out-of-pocket costs for union members and working families. 340B In Managing Healthcare Costs for Taft-Hartley Plans - Federal reforms would ensure the 340B program supports patient care without shifting costs on multi=employer health plans. Pending legislation would tighten rules on outpatient versus inpatient pricing, limit certain administrative costs, increase transparency, and add new requirements for 340B hospitals. S. 2658 Medication Affordability and Patent Integrity Act - Opposition to S. 2658 as there is no evidence of a systemic issue needing to be addressed by enacting such burdensome requirements for innovator companies, as well as for the USPTO. S.2305 Biosimilar Red Tape Elimination Act - Opposing S. 2305 as the bill is unnecessary. FDA already has the authority to approve biosimilar interchangeability without requiring switching studies and is exercising that authority in recently approved interchangeable biosimilars. Eliminating these standards will do nothing to improve patient access to biosimilars if they are excluded from coverage by PBMs and Health plans. S. 3014 Ensuring Timely Access to Generics Act of 2025 - Opposing S. 3014 as it would amend Section 505(q) of the FDCA to grant FDA authority to summarily deny 505(q) citizen petitions (about approval of generics, biosimilars, and 505(b)(2) applications) if the Agency determines either that the petition was submitted with the primary purpose of delay or does not on its face raise valid scientific or regulatory issues. The bill is unnecessary given FDA's existing authorities as well as FDA guidance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65429,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"L","last_name":"KOLBE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/75c7c239-4e13-4c44-966b-2991926b332f/","filing_uuid":"75c7c239-4e13-4c44-966b-2991926b332f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/75c7c239-4e13-4c44-966b-2991926b332f/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Patrick Foley","dt_posted":"2026-07-09T11:59:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3972 South Shore Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Port Republic","registrant_state":"MD","registrant_zip":"20676","registrant":{"id":401104104,"url":"https://lda.gov/api/v1/registrants/401104104/","house_registrant_id":null,"name":"E3 STRATEGIC CONSULTING GROUP","description":"Government Affairs Consultant","address_1":"3972 South Shore Drive","address_2":null,"address_3":null,"address_4":null,"city":"Port Republic","state":"MD","state_display":"Maryland","zip":"20676","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK WARD","contact_telephone":"+1 888-658-8484","dt_updated":"2026-07-29T11:26:26.677189-04:00"},"client":{"id":200765,"url":"https://lda.gov/api/v1/clients/200765/","client_id":36,"name":"PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION","general_description":"Association","client_government_entity":false,"client_self_select":null,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-10-30"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing and price controls, supply chain issues, pharmacy benefit managers transparency issues, intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act\"; S. 3345, \"PBM Price Transparency and Accountability Act\"; S. 2658, Medication Affordability and Patent Integrity Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64179,"prefix":null,"prefix_display":null,"first_name":"PATRICK","nickname":null,"middle_name":null,"last_name":"FOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/359a3ad5-4a9b-41f3-a8f9-5b5d31508f1b/","filing_uuid":"359a3ad5-4a9b-41f3-a8f9-5b5d31508f1b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/359a3ad5-4a9b-41f3-a8f9-5b5d31508f1b/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jessica Landacre","dt_posted":"2026-07-15T11:26:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1501 M STREET, NW, #1150","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":19547,"url":"https://lda.gov/api/v1/registrants/19547/","house_registrant_id":30664,"name":"INTELLECTUAL PROPERTY OWNERS ASSOCIATION","description":null,"address_1":"1501 M Street NW","address_2":"Suite 1150","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JESSICA LANDACRE","contact_telephone":"+1 202-507-4500","dt_updated":"2026-07-20T11:46:00.929681-04:00"},"client":{"id":126364,"url":"https://lda.gov/api/v1/clients/126364/","client_id":12,"name":"INTELLECTUAL PROPERTY OWNERS ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-01"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 1553 / H.R. 3160 PREVAIL Act S. 1546 / H.R. 3152 Patent Eligibility Restoration Act of 2025 (PERA) S. 1379 / H.R. 1566 REPAIR Act S. 2209 / H.R. 5155 Warrior Right to Repair Act of 2025 S. 4784 / H.R. 8800 National Defense Authorization Act S. 2658 Medication Affordability and Patent Integrity Act S. 43 / H.R. 6485 Skinny Labels, Big Savings Act S. 2276 / H.R. 3269 ETHIC Act (Eliminating Thickets to Increase Competition Act) H.R. 7015: Protecting Third Party Litigation Funding From Abuse Act S. 3826: Litigation Funding Transparency Act of 2026 H.R. 7389: Motor Vehicle Modernization Act of 2026 35 U.S.C. 5: Patent Public Advisory Committee (PPAC) and the Trademark Public Advisory Committee (TPAC) 35 U.S.C. 10: USPTO Fee-Setting Authority 15 U.S.C. 1125(d): Anti-Cybersquatting Consumer Protection Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":154097,"prefix":"ms","prefix_display":"MS.","first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GROVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":207,"name":"U.S. Copyright Office"},{"id":98,"name":"U.S. International Trade Commission (ITC)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/67b5714f-7362-43a2-86fd-22759280fe17/","filing_uuid":"67b5714f-7362-43a2-86fd-22759280fe17","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/67b5714f-7362-43a2-86fd-22759280fe17/print/","filing_document_content_type":"text/html","income":null,"expenses":"890000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-07-16T16:09:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S._____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. ___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act HR 5509, Safe Step Act, Provisions related step therapy protocols H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7391, the Community Health Center Drug Pricing Protection Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First S. 891, Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S.4784, An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes, Provisions related to the pharmaceutical industry. Smucker's VICP bill Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Vaccine policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/67b5714f-7362-43a2-86fd-22759280fe17/","filing_uuid":"67b5714f-7362-43a2-86fd-22759280fe17","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/67b5714f-7362-43a2-86fd-22759280fe17/print/","filing_document_content_type":"text/html","income":null,"expenses":"890000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-07-16T16:09:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S._____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. ___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act HR 5509, Safe Step Act, Provisions related step therapy protocols H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7391, the Community Health Center Drug Pricing Protection Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First S. 891, Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S.4784, An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes, Provisions related to the pharmaceutical industry. Smucker's VICP bill Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Vaccine policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7314f20b-5e14-4e73-801b-8986ee5658df/","filing_uuid":"7314f20b-5e14-4e73-801b-8986ee5658df","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7314f20b-5e14-4e73-801b-8986ee5658df/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jennifer Holmes","dt_posted":"2026-07-17T12:27:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"418 C St NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":400774330,"url":"https://lda.gov/api/v1/registrants/400774330/","house_registrant_id":null,"name":"S-3 GROUP","description":"Government consulting firm","address_1":"418 C St NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER HOLMES","contact_telephone":"+1 202-819-5036","dt_updated":"2026-07-25T19:32:13.062375-04:00"},"client":{"id":64053,"url":"https://lda.gov/api/v1/clients/64053/","client_id":64053,"name":"FRESENIUS KABI","general_description":"Healthcare/pharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148207,"prefix":null,"prefix_display":null,"first_name":"KRISTI","nickname":null,"middle_name":null,"last_name":"REMINGTON","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148207,"prefix":null,"prefix_display":null,"first_name":"KRISTI","nickname":null,"middle_name":null,"last_name":"REMINGTON","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7314f20b-5e14-4e73-801b-8986ee5658df/","filing_uuid":"7314f20b-5e14-4e73-801b-8986ee5658df","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7314f20b-5e14-4e73-801b-8986ee5658df/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jennifer Holmes","dt_posted":"2026-07-17T12:27:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"418 C St NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":400774330,"url":"https://lda.gov/api/v1/registrants/400774330/","house_registrant_id":null,"name":"S-3 GROUP","description":"Government consulting firm","address_1":"418 C St NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER HOLMES","contact_telephone":"+1 202-819-5036","dt_updated":"2026-07-25T19:32:13.062375-04:00"},"client":{"id":64053,"url":"https://lda.gov/api/v1/clients/64053/","client_id":64053,"name":"FRESENIUS KABI","general_description":"Healthcare/pharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148207,"prefix":null,"prefix_display":null,"first_name":"KRISTI","nickname":null,"middle_name":null,"last_name":"REMINGTON","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148207,"prefix":null,"prefix_display":null,"first_name":"KRISTI","nickname":null,"middle_name":null,"last_name":"REMINGTON","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6caaccc6-eb58-4812-b5d3-89f72acfa90a/","filing_uuid":"6caaccc6-eb58-4812-b5d3-89f72acfa90a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/6caaccc6-eb58-4812-b5d3-89f72acfa90a/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jonathon Jones, Partner","dt_posted":"2026-07-18T14:16:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"750 9th Street NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":20744,"url":"https://lda.gov/api/v1/registrants/20744/","house_registrant_id":31587,"name":"TIBER CREEK GROUP","description":"Government Relations.","address_1":"750 9th Street NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GRACE BAUM","contact_telephone":"+1 202-381-6896","dt_updated":"2026-07-20T13:07:00.819992-04:00"},"client":{"id":58745,"url":"https://lda.gov/api/v1/clients/58745/","client_id":58745,"name":"PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION","general_description":"Biopharmaceutical coalition supporting job creation and medical innovation.","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to IP protection under Bayh Dole; Issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing; Issues related to S. 2658 - Medication Affordability and Patent Integrity Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107185,"prefix":null,"prefix_display":null,"first_name":"COREY","nickname":null,"middle_name":null,"last_name":"MALMGREN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to IP protection under Bayh Dole; Issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107185,"prefix":null,"prefix_display":null,"first_name":"COREY","nickname":null,"middle_name":null,"last_name":"MALMGREN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/70494441-3fb4-4099-829b-ffd9b717efe3/","filing_uuid":"70494441-3fb4-4099-829b-ffd9b717efe3","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/70494441-3fb4-4099-829b-ffd9b717efe3/print/","filing_document_content_type":"text/html","income":null,"expenses":"140000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Christopher Porter","dt_posted":"2026-07-20T08:09:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3611 Valley Centre Drive","registrant_address_2":"Suite 300","registrant_different_address":true,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401104190,"url":"https://lda.gov/api/v1/registrants/401104190/","house_registrant_id":null,"name":"TRAVERE THERAPEUTICS","description":"Pharmaceuticals","address_1":"3611 Valley Centre Drive","address_2":"Suite 300","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTOPHER PORTER","contact_telephone":"+1 877-969-7879","dt_updated":"2026-07-20T10:56:00.116563-04:00"},"client":{"id":200929,"url":"https://lda.gov/api/v1/clients/200929/","client_id":12,"name":"TRAVERE THERAPEUTICS","general_description":"Biopharmaceuticals","client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-08-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. HR 1518, the New Era of Preventing End-Stage Kidney Disease Act; end-stage renal disease policy and rare kidney disease","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"HR 946 and S. 1862, Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act); related provisions in H.R.1, One Big Beautiful Bill Act; Most Favored Nation and international reference pricing proposals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"HR 1262, S 932 Give Kids a Chance Act to renew PRV program; related provisions in H.R.1, One Big Beautiful Bill Act; HR 4709, the Newborn Screening Saves Lives Reauthorization Act; PDUFA/regulatory review process; H.R. 9102, Biotech Investment National Security Act (BINSA)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Regulations regarding transparency, reimbursement and care, particularly regarding rare disease. Medicare and Medicaid related provisions in H.R.1, One Big Beautiful Bill Act.H.R. 9509, the Kidney Disease Education Expansion Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S.1040, to prohibit product hopping and for other purposes; proposals regarding patent thickets. S. 2658, Medication Affordability and Patent Integrity Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1414, Cameron's Law to increase Orphan Drug Tax Credit to 50%; R&D tax credit; related implementation provisions in H.R.1, One Big Beautiful Bill Act; pharmaceutical tariffs, specifically related to orphan drugs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64866,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141299,"prefix":null,"prefix_display":null,"first_name":"ROSE","nickname":null,"middle_name":null,"last_name":"GALLAGHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/dd31025d-92a7-4fb3-87ab-b3fc6ae1d498/","filing_uuid":"dd31025d-92a7-4fb3-87ab-b3fc6ae1d498","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/dd31025d-92a7-4fb3-87ab-b3fc6ae1d498/print/","filing_document_content_type":"text/html","income":null,"expenses":"1880000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennie Skelton","dt_posted":"2026-07-20T12:39:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1275 Pennsylvania Avenue, NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31326,"url":"https://lda.gov/api/v1/registrants/31326/","house_registrant_id":31354,"name":"PFIZER INC.","description":"Biopharmaceuticals","address_1":"1275 Pennsylvania Avenue, NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIE SKELTON","contact_telephone":"+1 415-903-2800","dt_updated":"2026-08-21T13:00:31.079287-04:00"},"client":{"id":138225,"url":"https://lda.gov/api/v1/clients/138225/","client_id":12,"name":"PFIZER INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-02-15"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual Property Protections and Policy S. 2658 - Medication Affordability and Patent Integrity Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Codification and Sec. 301 trade investigations FDA User Fee Agreements: 2027 PDUFA Cycle H.R. 7837 - Most Favored Patient Act of 2026 H.R. 7391 - Community Health Center Drug Pricing Protection Act 340B Program Reform Inflation Reduction Act (IRA) H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriates Act, 2027 H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Act, 2027 H.R. 5178 - Sickle Cell Disease Comprehensive Care Act H.R. 5526 - Biosimilars Red Tape Elimination Act H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act: IRA reforms Prior Authorization Step Therapy Practices FDA Modernization and Reforms Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106110,"prefix":null,"prefix_display":null,"first_name":"FRANCISCO","nickname":null,"middle_name":null,"last_name":"CARRILLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 7391 - Community Health Center Drug Pricing Protection Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Vaccine Access and Coverage 340B Program Reform PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage Step Therapy Practices Drug Pricing Medicare/Medicaid Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106110,"prefix":null,"prefix_display":null,"first_name":"FRANCISCO","nickname":null,"middle_name":null,"last_name":"CARRILLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1 - An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"H.R. 9102 - Biotech Investment National Security Act (BINSA) Act: US Competitiveness, Biotechnology H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade International Supply Chain Section 301 Investigation re: Germany Issues Market Access Most Favored Nation Policies Foreign Freeriding Issues Non-Tariff Trade Barriers Competitiveness Issues Trade Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72512,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"CLAEYS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69774,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/56c417c4-af8a-4fe1-bc2c-2c2f4797753e/","filing_uuid":"56c417c4-af8a-4fe1-bc2c-2c2f4797753e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/56c417c4-af8a-4fe1-bc2c-2c2f4797753e/print/","filing_document_content_type":"text/html","income":null,"expenses":"260000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Thomas Kraus","dt_posted":"2026-07-20T12:49:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4500 East West Highway","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"BETHESDA","registrant_state":"MD","registrant_zip":"20814","registrant":{"id":3457,"url":"https://lda.gov/api/v1/registrants/3457/","house_registrant_id":31550,"name":"AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS","description":null,"address_1":"4500 East West Highway","address_2":"Suite 900","address_3":null,"address_4":null,"city":"BETHESDA","state":"MD","state_display":"Maryland","zip":"20814","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"THOMAS KRAUS","contact_telephone":"+1 301-664-8692","dt_updated":"2026-08-28T12:41:14.961896-04:00"},"client":{"id":103667,"url":"https://lda.gov/api/v1/clients/103667/","client_id":12,"name":"AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to vaccine access and evidence-based resources for patients and pharmacists (generally, no specific legislation). Tylers Law (H.R. 2004), the ALERT Communities Act (H.R. 1561), and the HERO Act (H.R. 7994), issues related to access to fentanyl test strips and medications for opioid use disorder (MOUD). The Eliminating Thickets to Increase Competition Act (ETHIC) Act (H.R. 3269), the Affordable Prescriptions for Patents Act (H.R. 1768), the Skinny Labels, Big Savings Act (H.R. 6485), the Medication Affordability and Patent Integrity Act (S. 2658), and the Ensuring Timely Access to Generics Act of 2025 (S. 3014), issues related to drug pricing, drug shortages, drug importation plans, and the drug supply chain. Issues related to telehealth and pharmacist provision of testing and vaccination (generally, no specific legislation). Patient access to pharmacist provided services for respiratory illnesses, initiation of oral antivirals, buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation). Issues related to healthcare workforce shortages (generally, no specific legislation). The Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 929/S. 266), provisions related to supporting health workers mental health and well-being. Issues related to implementation of the Inflation Reduction Act (generally, no specific legislation). The Drug-Price Transparency for Consumers (DTC) Act (H.R.3789), issues related to direct-to-consumer (DTC) prescription drug advertising. The Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646), issues related to funding of FDA. Issues related to the Substance Abuse and Mental Health Services Administration (SAMHSA) decision to end the use of federal funds to purchase fentanyl test strips or other substance test kits, including xylazine and medetomidine test strips, that are distributed for individual use. Issues related to mail-order access to mifepristone (generally, no specific legislation). Issues related to pharmacist deprescribing medications (generally, no specific legislation). The Medication Affordability and Patent Integrity Act, issues related to preventing manufacturers from filing inconsistent information with the Food and Drug Administration and the U.S. Patent and Trademark Office, with the intent to unfairly extend product exclusivity. The Improving Seniors Timely Access to Care Act of 2025 (H.R. 3514) and the Prior Authorization Accountability Act (H.R. 9396), issues related to prior authorization.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71013,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"KRAUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141165,"prefix":null,"prefix_display":null,"first_name":"FRANK","nickname":null,"middle_name":null,"last_name":"KOLB","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":63877,"prefix":null,"prefix_display":null,"first_name":"JILLANNE","nickname":null,"middle_name":null,"last_name":"SCHULTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"The Main Street Pharmacy Access Act/Ensuring Community Access to Pharmacist Services Act (H.R. 3164/S. 2426), including reimbursement for pharmacist provision of testing and vaccination. Issues related to telehealth reimbursement and virtual supervision flexibilities for pharmacist services with CMS (generally, no specific legislation). Issues related to extension of site-neutral policies to drug administration services in hospital provider-based departments (generally, no specific legislation). Issues related to implementation of Medicare drug price negotiation (generally, no specific legislation). Issues related to removal of administrative barriers to pharmacist services in Medicare Advantage (generally, no specific legislation). Issues related to CMS proposed rules, including the inpatient prospective payment system (IPPS) proposed rule, the proposed rule on interoperability and prior authorization (PA) for drugs, the outpatient prospective payment system (OPPS) proposed rule, and the physician fee schedule (PFS) proposed rule.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63877,"prefix":null,"prefix_display":null,"first_name":"JILLANNE","nickname":null,"middle_name":null,"last_name":"SCHULTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71013,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"KRAUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141165,"prefix":null,"prefix_display":null,"first_name":"FRANK","nickname":null,"middle_name":null,"last_name":"KOLB","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"The Rebuild Americas Health Care Schools Act (H.R. 1708/S. 1087), issues related to pharmacy residency funding. Issues related to FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. The Biosimilar Red Tape Elimination Act (H.R. 5526/S. 1954) and Expedited Access to Biosimilars Act (H.R. 9661), issues related to increased patient access to essential biosimilar medications. Issues related to pharmacy benefit manager (PBM) abuses and transparency (generally, no specific legislation). The 340B PATIENTS Act (H.R. 4581/S. 2372), issues related to 340B program nondiscrimination and contract pharmacy arrangements. Issues related to manufacturer attempts to undercut the 340B program, including conversion of the program to a rebate model (generally, no specific legislation). Issues related to drug price negotiations and patient out-of-pocket costs (generally, no specific legislation). Issues related to patient access to antipsychotic medication in long-term care settings (generally, no specific legislation). The Stop Pills That Kill Act (H.R. 8005), PRESS Act (H.R. 7184), and Fight Illicit Pill Presses Act (H.R. 5880), issues related to halting the unlawful production and availability of fentanyl, fentanyl analogues, and fentanyl-related substances. The States Handling Access to Reciprocity for Employment (SHARE) Act of 2025 (H.R. 4122), issues related to the Federal Bureau of Investigation (FBI) providing criminal history records to state licensing agencies under interstate compacts, which would help pharmacists and other healthcare professionals to more easily work across state lines.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63877,"prefix":null,"prefix_display":null,"first_name":"JILLANNE","nickname":null,"middle_name":null,"last_name":"SCHULTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71013,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"KRAUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141165,"prefix":null,"prefix_display":null,"first_name":"FRANK","nickname":null,"middle_name":null,"last_name":"KOLB","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7ba229b3-435d-4ecd-a51a-018dfd969e12/","filing_uuid":"7ba229b3-435d-4ecd-a51a-018dfd969e12","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7ba229b3-435d-4ecd-a51a-018dfd969e12/print/","filing_document_content_type":"text/html","income":null,"expenses":"790000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tricia Brooks","dt_posted":"2026-07-20T12:58:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"200 Metro Boulevard","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Nutley","registrant_state":"NJ","registrant_zip":"07110","registrant":{"id":400321512,"url":"https://lda.gov/api/v1/registrants/400321512/","house_registrant_id":40258,"name":"EISAI INC.","description":"Pharmaceutical development, manufacturing and distribution -- Health Care","address_1":"200 Metro Boulevard","address_2":null,"address_3":null,"address_4":null,"city":"Nutley","state":"NJ","state_display":"New Jersey","zip":"07110","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TRICIA BROOKS","contact_telephone":"+1 202-934-3735","dt_updated":"2026-07-22T11:30:31.993646-04:00"},"client":{"id":189281,"url":"https://lda.gov/api/v1/clients/189281/","client_id":12,"name":"EISAI INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-28"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Supply chain manufacturing and tariffs, including: the Section 232 and Section 301 tariff investigations related to branded pharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Pharmaceutical Intellectual Property (IP), including: S. 2658, Medication Affordability and Patent Integrity Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Pharmaceutical manufacturing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; Pharmacy Benefit Manager (PBM) reform, 340B Drug Discount Program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"General Medicare and Medicaid including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; Center for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax reform, including: H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7f892462-d586-4f79-a9fa-8025deea583d/","filing_uuid":"7f892462-d586-4f79-a9fa-8025deea583d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7f892462-d586-4f79-a9fa-8025deea583d/print/","filing_document_content_type":"text/html","income":null,"expenses":"240000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Bill McCarthy","dt_posted":"2026-07-20T13:12:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1800 M Street, NW, Suite 800 S","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":401105458,"url":"https://lda.gov/api/v1/registrants/401105458/","house_registrant_id":null,"name":"FDD ACTION","description":"Issue advocacy on U.S. national security and foreign policy","address_1":"1800 M Street, NW, Suite 800 S","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM MCCARTHY","contact_telephone":"+1 202-207-0190","dt_updated":"2026-07-17T14:19:22.246604-04:00"},"client":{"id":203727,"url":"https://lda.gov/api/v1/clients/203727/","client_id":12,"name":"FDD ACTION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-10-01"},"lobbying_activities":[{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"H.R. 1422, Enhanced Iran Sanctions Act, all provisions. H.R. 1800, Solidify Iran Sanctions Act (SISA), all provisions. H.R. 2683, Remote Access Security Act, all provisions. H.R. 3447, Chip Security Act, all provisions. H.R. 425, Repealing Big Brother Overreach Act, all provisions. H.R. 4397, Muslim Brotherhood Terrorist Designation Act of 2025, all provisions. H.R. 4505, Export Controls Enforcement Act, all provisions. H.R. 4530, STOP Shells Act, all provisions. H.R. 4920, BIS IT Modernization Act, all provisions. H.R. 4930, Counterfeit Notification Act, all provisions. H.R. 5490, Dismantle Foreign Scam Syndicates Act, all provisions. H.R. 5853, ECRA Penalty Increase Act, all provisions. H.R. 6058, Semiconductor Technology Resilience, Integrity, and Defense Enhancement (STRIDE) Act, all provisions. H.R. 6322, Stop Stealing Our Chips Act, all provisions. H.R. 6331, Addressing Dangerous Vulnerabilities in Exports and Research to Strategic Adversaries, Regimes, and Industrial Entities of Security Concern (ADVERSARIES) Act, all provisions. H.R. 6624, Biological Intellectual Property Protection Act of 2025, all provisions. H.R. 6875, AI OVERWATCH Act, all provisions. H.R. 6996, Full AI Stack Export Promotion Act, all provisions. H.R. 7003, BIS Strategic Talent Recruitment to Enhance National Guardrails for Technological Handling (STRENGTH) Act, all provisions. H.R. 7184, Preventing Rogue Equipment for Synthetic Substances (PRESS) Act, all provisions. H.R. 7552, CBW Fentanyl Act, all provisions. H.R. 8036, Interagency Coordination in Export Controls Act, all provisions. H.R. 8106, Rosatom Energy Sanctions Compliance and Unified Enforcement (RESCUE) Act, all provisions. H.R. 8169, Export Control Enforcement and Enhancement Act, all provisions. H.R. 8170, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act, all provisions. H.R. 8202, ECRA Statute of Limitations Extension, all provisions. H.R. 8283, Deterring American AI Model Theft Act of 2026, all provisions. H.R. 8284, Bureau of Industry and Security License Administration Enhancement Act, all provisions. S. 1473, Stop Stealing our Chips Act, all provisions. S. 1490, Global Hunt for Offshore Smuggling and Trafficking (GHOST) Act of 2025, all provisions. S. 1705, Chip Security Act, all provisions. S. 1889, Solidify Iran Sanctions Act (SISA), all provisions. S. 2293, Muslim Brotherhood Terrorist Designation Act of 2025, all provisions. S. 2677, Counterfeit Notification Act, all provisions. S. 2904, Sanctioning Harbors and Dodgers of Western Sanctions (SHADOW) Fleets Act, all provisions. S. 3172, A bill to repeal certain Acts that impose sanctions upon Syria, all provisions. S. 3452, Biological Intellectual Property Protection Act of 2025, all provisions. S. 3519, Remote Access Security Act, all provisions. S. 4281, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act, all provisions. S. 4446, Preventing Rogue Equipment for Synthetic Substances (PRESS) Act, all provisions. S. 4456, AI OVERWATCH Act, all provisions. S. 4723, Eliminate PRC Organized Crime Act, all provisions. S. 4835, Bureau of Industry and Security License Administration Enhancement Act, all provisions. S. 556, Enhanced Iran Sanctions Act of 2025, all provisions. S. 63, CBW Fentanyl Act, all provisions. Issues Related to American Economic Statecraft; Anti-Money Laundering and Combating the Financing of Terrorism; Captagon, Fentanyl, and International Narcotics Production and Trafficking; China-Related Tax and Investment Authorities; Chinese Access to U.S. Capital Markets and Advanced Technology; DIB Capacity Tax Incentives; Evaluating Sanctions, Export Controls, and AML Regulations, Regulatory Authorities, and Legislative Authorities; Expansion of CFIUS Authorities; Foreign Investment in Latin America; Hezbollah, Iran, and IRGC Funding Streams; Implementation and Oversight of the Corporate Transparency Act; Implementation and Oversight of the Countering Americas Adversaries Through Sanctions Act (CAATSA); Implementation and Oversight of the Foreign Extortion Prevention Act; Iranian Oil Sanctions Enforcement; Muslim Brotherhood Funding Streams; National Security-Related Foreign Investment Screening Processes for U.S. Allies; Tax-Exempt Status of Organizations with Ties to U.S. Adversaries; U.S. Adversaries Illicit Finance Activities; U.S. Adversaries Sanctions Evasion Schemes; U.S. Anti-Corruption Sanctions and Strategy; U.S. China Sanctions Policy; U.S. Cuba Sanctions Policy; U.S. Export Control Policy; U.S. Houthi Sanctions Policy; U.S. International Sovereign Debt Policy; U.S. Investment Screening and Security; U.S. Iran Sanctions Policy; U.S. Iraq Sanctions Policy; U.S. Muslim Brotherhood Sanctions Policy; U.S. Nicaragua Sanctions Policy; U.S. Oman Sanctions; U.S. Polisario Front Sanctions Policy; U.S. Russia Oil Waivers and Sanctions Policy; U.S. Sanctions Authorities, Implementation, Enforcement, Resourcing, and Policy; U.S. Syria Sanctions Policy; U.S. Terror Finance Policy; and U.S. Turkey Sanctions Policy (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145330,"prefix":"mr","prefix_display":"MR.","first_name":"NICHOLAS","nickname":"NICK","middle_name":null,"last_name":"STEWART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.Con.Res. 38, Directing the President pursuant to section 5(c) of the War Powers Resolution to remove United States Armed Forces from unauthorized hostilities in the Islamic Republic of Iran, all provisions. H.Con.Res. 40, Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove United States Armed Forces from hostilities with Iran, all provisions. H.Con.Res. 75, Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove the United States Armed Forces from hostilities against the Islamic Republic of Iran, all provisions. H.Con.Res. 84, Directing the President pursuant to section 5(c) of the War Powers Resolution to remove United States Armed Forces from Lebanon, all provisions. H.Con.Res. 86, Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove United States Armed Forces from hostilities with Iran, all provisions. H.J.Res. 176, 2026 Authorization for Use of Military Force Against Iran, all provisions. H.J.Res. 200, Providing for congressional disapproval of the proposed foreign military sale to Turkey of certain defense articles and services, all provisions. H.R. 2505, Block the Use of Transatlantic Technology in Iranian Made Drones Act, all provisions. H.R. 7126, Securing Essential and Critical U.S. Resources and Elements (SECURE) Minerals Act, all provisions. H.R. 7146, Providing Our Regional Companions Upgraded Protection in Nefarious Environments (PORCUPINE) Act, all provisions. H.R. 7178, U.S.-Israel Anti-Killer Drone Act, all provisions. H.R. 7273, NASA Reauthorization Act of 2026, all provisions. H.R. 7540, United States-Israel Framework for Upgraded Technologies, Unified Research, and Enhanced Security (FUTURES) Act of 2026, all provisions. H.R. 8019, U.S.-Greece Defense Cooperation Advancement Act, all provisions. H.R. 8069, Strategic Subsea Cables Act of 2026, all provisions. H.R. 8168, Major Non-NATO Ally Terror Threat Assessment Act, all provisions. H.R. 8177, Critical Undersea Infrastructure Resilience Initiative Act, all provisions. H.R. 8649, Expanding the Defense Industrial Base Sales Act, all provisions. H.R. 8665, Allied Defense Sales Act, all provisions. H.R. 8787, Servicemember Payment Data Privacy and Security Act, all provisions. H.R. 9232, Critical Infrastructure Airspace Defense Act, all provisions. H.R. 9256, Ending Child Soldiers in Africa Act, all provisions. H.R. 9322, Abraham Accords Defense Cooperation Act of 2026, all provisions. H.R. 9366, Eastern Frontier Defense Infrastructure Readiness Act, all provisions. H.R. 9451, Seized Assets for Battlefield Equipment and Readiness (SABER) Act, all provisions. H.R. 9495, Department of Defense Appropriations Act, 2027, (issues related to U.S.-Ukraine Security Cooperation). H.R. 9550, Strategic Unmanned Systems Partnership Act, all provisions. H.Res. 1246, Expressing the sense of the House of Representatives in support of the integration of Kosovo into the North Atlantic Treaty Organization, all provisions. H.Res. 564, Calling for the return of abducted Ukrainian children before finalizing any peace agreement to end the war against Ukraine, all provisions. S. 1744, Providing Our Regional Companions Upgraded Protection in Nefarious Environments (PORCUPINE) Act, all provisions. S. 1962, Secure Space Act of 2025, all provisions. S. 2222, Critical Undersea Infrastructure Resilience Initiative Act, all provisions. S. 3249, Strategic Subsea Cables Act of 2026, all provisions. S. 3404, Satellite Cybersecurity Act of 2025, all provisions. S. 3659, Securing Essential and Critical U.S. Resources and Elements (SECURE) Minerals Act, all provisions. S. 3855, United States-Israel Framework for Upgraded Technologies, Unified Research, and Enhanced Security (FUTURES) Act, all provisions. S. 4219, Abraham Accords Defense Cooperation Act of 2026, all provisions. S. 4380, Critical Infrastructure Airspace Defense Act, all provisions. S. 4443, Eastern Mediterranean Gateway Act, all provisions. S. 4544, Stop Fueling Cartel Violence Act, all provisions. S. 4711, Strategic Unmanned Systems Partnership Act, all provisions. S. 4826, Seized Assets for Battlefield Equipment and Readiness (SABER) Act, all provisions. S. 933, NASA Transition Authorization Act of 2025, all provisions. S.J.Res. 114, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.J.Res. 123, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.J.Res. 163, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.J.Res. 184, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.J.Res. 185, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.Res. 236, A resolution calling for the return of abducted Ukrainian children before finalizing any peace agreement to end the war against Ukraine, all provisions. H.R. 8800, National Defense Authorization Act for Fiscal Year 2027, (issues related to Actions to Evaluate and Invest in Ukrainian Defense Technologies; Additional Support for NATO Air Defense Against UAS; AI Agent Discovery and Security Standards; Air Force Fighter Fleet Recapitalization; Amendment to the Atomic Energy Act of 1954; Amendments to the Anti-Boycott Act of 2018; American Security Robotics Act; American-Hellenic-Israeli Eastern Mediterranean Counterterrorism and Maritime Security Partnership Act; Analysis of Threats Posed by Foreign Adversary Access to Controlled Items Within the US; ARMOR Act; Assessment and Report of Foreign Adversary Influence over Strategic Maritime Chokepoints; Assessment of Antisemitism in the Service Academies; Assessment of DOD Display Chain Supply Chain Vulnerabilities; Assessment of Foreign Adversary-Controlled Digital Platforms; Assessment of Military Medical Supply Chains; Assessment of Resilient Missile Defense Sensing Architectures; Assessment of Russian Involvement in Narcotics and Narcotics Trafficking; Audit and Mitigation of Certain Cellular Modules; Audit of CCP-Linked Participation in DOD Contracts and Supply Chains; Baltic Region Security Concerns; Biological Intellectual Property Protection Act; Biotech Investment National Security Act; Briefing on Supply Chain Exposure; Briefing on the Pilot Program to Analyze and Monitor Certain Supply Chains; Bunker Buster Act; Certification Requirement for Motor Carriers Transporting DOD Freight; Certification That No Contractor of DOD Participates in BDS Movement; Chinese Cellular Modules; Chinese Commercial Space Capabilities; Chinese Robotics Capabilities and Strategy; Chinese Supply Chain Monopoly Identification and Diversification; Civilian Cybersecurity Reserve Corps Pilot Program; Clarification of Authority to Counter UAS for Members of the National Guard; Classification of Pass-Through Funding Within Defense Budget Materials; CLEAR Path Act; Codification of EOs Relating to American Airspace Sovereignty and Drone Dominance; Commercial Software for Contested Logistics; Countering Adversarial Gray Zone Campaigns; Countering Biotechnology Threats from Foreign Adversaries; Countering Cartel Hydrocarbon Smuggling; Countering Iranian Threat Networks in the Eastern Mediterranean; Criminal Penalties for Providing Material Support to a Covered Foreign Country; Critical Minerals Traceability Pilot Program; Cyber Incident Reporting Requirements for Operationally Critical Contractors; Deter PRC Aggression Against Taiwan Act; Determination on Eligibility for Cyber Pilot Program; DETERRENCE Act; DETERRENT Act; Development, Test, Evaluation, Demonstration, and Transition to Production of Alternative Low-Cost Weapon Systems; Dialogue and Measures with Respect to Moldova; DIB and Acquisition Reform; Disclosure of Foreign Funding for Elementary and Secondary Schools; DOD Economic Defense Unit; DOD Grant Program to Improve Cybersecurity Resilience of Department-Owned Joint-Use Airports; Domestic and Covered Allied or Partner Country Critical Transportation Manufacturing Assessment; Domestic Production of Short-Wave Infrared Quantum Dot Materials; Electromagnetic Spectrum Operations Review; Elimination of Use of Certain Payment Processing Equipment, Systems, or Services; End the Cyprus Embargo Act; Ensuring Mature-node Semiconductor Availability; Establishment of Army Information Operations Center of Excellence; Establishment of China Watcher Program; Establishment of DIU Office in Israel; Establishment of Eastern Flank NATO Regional SOC and CSIRT Program; Establishment of Strategic Airports Cybersecurity Infrastructure Program; Establishment of US-Israel AI Center; Establishment of US-Ukraine Critical Minerals Investment Screening Mechanism; Evaluation of Standards for EMP Protection; Exceptions for Notifications to the US Government Relating to Specified Foreign Entities; Expanding the Defense Industrial Base Sales Act; Expansion of Permissible Uses of Ukraine Support Fund; Extension and Modification of Indo-Pacific Maritime Security Initiative; Extension and Modification of Report on Military and Security Developments Involving the PRC; Extension of Limitation on Availability of Funds for the Iraqi Security Forces; Extension of Report on IRGC-Affiliated Operatives Abroad; FASC Exclusion Orders for Chinese Military Company Designees; Feasibility of Permanent Basing an F-35 Squadron in Poland; Feasibility Study on Combatant Command Critical Minerals Management; Feasibility Study on Tactical Information Operations Command Authority; GAO Report on AI Integration Across Defense Operations; Government-Wide Critical Mineral Procurement and Resale Authorities Feasibility Study; GPS Modernization; GUARD Act; Guard the Skies Act; Hardware and Firmware Assurance Pilot Program; IMF Reform; Increased Maximum Production Capacity Plans for Key Munitions and Weapons Systems; Indo-Pacific Trilateral Production Pilot Program; Integrated Air and Missile Defense Architecture; Integration of Demand for FMS into Industrial Base Planning; Internal Base Hardening Assessments and Logistics-Node Threat Mitigation; Joint DOD-DHS Security Pilot Program on Prevention of Terrorist Threats Involving Motor Vehicles; Joint US-Taiwan Research, Development, Test, and Evaluation Program; Limitation on Provision of Funds to Elementary and Secondary Schools Hosting Confucius Institutes and Classrooms; Long Range Anti-Ship Missile Surface and Ground Launch; Maritime Security Measures; Medical Supply Chain Risk Identification and Transparency Enhancement; Military Treatment Facility Readiness, Network Reliance, and Cyber Resilience; Modification of Report on Military and Security Developments Involving Russia; Modification of Report on the Military Power of Iran; Modification to Disclosure Requirements for US-Based Foreign Media Outlets; Modifications to Congressional Review of Sanctions with Respect to Russia; Modifications to Public Reporting of Chinese Military Companies Operating in the US; Modifications to Strategy to Eliminate Sourcing of Computer Displays from Certain Nations; Modifications to the Port Security Grant Program; Moldovas Airspace Awareness and Defense Capabilities; MTS Cyber Act; Multiyear Procurement Authorities; National Security Commission on Robotics; NSA Support for DIB and Critical Infrastructure Cybersecurity Operations; Oversight of Military-to-Military Exchanges and Contacts Between the US and Russia; PAID OFF Act; Participation of Ukrainian Students in US Service Academies; Phased Inventory Benchmarks for Combat Coded Fighter Aircraft; Photovoltaic Modules from Foreign Entities of Concern; PILLAR Act; Pilot Program for Adaptive Electronic Warfare-Resilient and Quantum-Secure Autonomy Small UAS Architecture Testing; Pilot Program on DOD Partnerships with IHE Recognized in the NCAE-C Program for Cyber Research; Pilot Program on National Security Risk Identification and Review for Adversarial Capital; Pilot Program on Semiconductor Antitampering and Authenticity Validation; Pilot Program to Improve Participation by Small Business Concerns in Certain DOD Contracts; Plan on Remediation of Certain Equipment and Computational Facilities Owned or Controlled by a Foreign Adversary; Plan Required for Full Participation by Taiwan in the RIMPAC; Plan to Counter PRC Influence and Activities in the FAS; Potential Designation of Information as a Domain of Warfare; PRC Militarization and Surveillance Activities; Procurement of Amoxicillin; Prohibition Against US Recognition of Russia's Claim of Sovereignty over Any Portion of Ukraine; Prohibition on DOD Procurement from, and Servicemember Data Collection by, Companies Storing Data in a Covered Foreign Country; Prohibition on Operation or Procurement of Foreign-Made UAS; Prohibition on Procurement and Operation of Covered Robotic Systems; Prohibition on Procurement by DOD and IC of Chinese-Made Synthetic Datasets for Training AI Models; Prohibition on Transfers to the Badr Organization; Prohibition on TSP Investments; Prohibition on Use of Funds for Ukraine Security Assistance; Protecting US Farmland and Sensitive Sites from Foreign Adversaries Act; Protection of Supply Chain of Certain Drugs; Rail Infrastructure Cybersecurity Enhancement Program; Real-Time and AI-Enabled Property Records; Report and Conditions on Security Assistance to Oman; Report on Accelerating Military Posture Within Area of Responsibility of US INDOPACOM; Report on Counterintelligence Risks Associated with Real Property Transactions Near Military Installations; Report on Dependency on China for Processing Materials for DOD Supply Chains; Report on Forced Conscription of Kidnapped Ukrainian Children into Russian Armed Forces; Report on Foreign-Linked Funding of Legal and Administrative Actions Targeting US and Allied Personnel; Report on Global Automobile Theft Rings; Report on Instances of Antisemitism; Report on Involvement of Certain Foreign Actors in Antisemitic Activity in the US; Report on Military Power and Illicit Activities of Certain Drug Cartels; Report on Modernization of the Aegis Ashore Missile Defense Site at Devesselu, Romania; Report on Moldova Airspace Defense Requirements and Options; Report on PRC Space Capabilities; Report on Production of 155MM Artillery Ammunition; Report on Protection of US Defense Technology; Report on Russias Targeting of Religious Infrastructure in Ukraine; Report on Russian Active Measures in NATO Territory; Report on Russian Efforts in Sudan; Report on Russian Influence in Libya; Report on Russian Influence; Report on Russian Military Presence in Syria; Report on Security Risks Posed by Turkeys Occupation of Cyprus; Report on Taiwan Capabilities and Intelligence Support; Report on the Feasibility of Requiring Bills of Materials for Defense Acquisition; Report on the National Security Implications of Applying Nondiscriminatory Treatment to the PRC; Report on the PRC and Turkey Military and Intelligence Cooperation; Report on Turkey Aiding Hamas or Its Affiliates; Report to Congress on Energy in Moldova; Reporting on Russias Military Power and Capabilities; Reports on Cyber Operational Readiness Assessment Program; Re-Purposing Aircraft from the 309th AMARG; Requirement for Guidance and Prohibition on Use of AI of Certain AI Companies; Requirement for Memoranda of Agreement Regarding Vulnerability Disclosure and Prohibition on Procurement from IT Providers Who Can Share Cyber Vulnerabilities with Countries of Concern; Requirements Related to Certain Sanctions on Russia or Belarus; Restriction on Providing Federal Funds to Certain Entities for Public Works Projects; Restrictions on US Support for Economic Activities Involving Persons Who Benefitted from or Supported the Assad Regime; Review of Intelligence Vulnerabilities of Internet Connected Video Surveillance Equipment on Military Installations; Revocation of Security Clearances for Certain Persons; Safeguarding DOD-Funded Research; Securing Critical US Infrastructure and Mineral Supply Chains; Securing DOD Supply Chains; Securing Innovation and Research from Adversaries Act; Seizure and Forfeiture of Assets of Russian Kleptocrats; Semiconductor Controls Adjusted to Limit Exports Act; Semiconductor Supply Chain Security and Diversification Act; Sense of Congress on Commitment to the AUKUS Partnership; Sense of Congress on Domestic Production of Artillery Projectiles; Sense of Congress on International Defense Exhibitions; Sense of Congress on Nuclear Cooperation Agreements with Saudi Arabia; Sense of Congress on the Gaza Health Ministry; Sense of Congress on the Permanent and Rotational Presence of US Forces in Romania; Sense of Congress Regarding Kosovo Integration into NATO; Sense of Congress Regarding NATO's Kosovo Force; Sense of Congress with Respect to Execution of Warrants of the ICC; Space-Based Missile Defense Strategy; Standards for AI Systems; Strategic Partnership on Defense Industrial Priorities Between the US and Taiwan; Strategy for Establishing a Two-Way Transfer Mechanism for US-Ukraine UAS Expertise; Strategy for the Adoption and Integration of AI; Strategy to Defend Against Risks Posed by the Use of AI; Strategy to Restore Stability to the Western Balkans; Strengthening Continuity of the Economy Planning; Study and Report on International Security Measures on the Border Between Gaza and Egypt; Study, Strategy, and Report on DOD Reliance on Transportation Systems Incorporating Chinese-Origin Components; Taiwan-Five Eyes Cyber Defense Cooperation Initiative; Training for Ukraines Military and National Security Forces; Transatlantic Growth Enterprise Act; Tren de Aragua Border Security Threat Assessment Act; Ukraine Drone Production and Strategy; Ukrainian Military Instructors at Senior Professional Military Education Institutions; Updated Middle East IAMD Strategy; Updates to Certain Asset Lists of the DOD; Upholding the Dayton Peace Agreement Through Sanctions Act; US Counter-Robotics Strategy; US Cybersecurity Capabilities and Strategy; US Drone and Missile Defense Capabilities; US Force Posture in Korea and Europe, US Information Operations Capabilities and Strategy; US International Legal Operations Strategy; US Military Posture in Europe; US-Abraham Accords Defense Cooperation Initiative; US-Cyprus Security Cooperation; USDT Report on Financial Institutions That Support Terrorist Activity; US-European Nuclear Energy Cooperation Act; US-Greece Security Cooperation Reporting Act; US-Israel Cooperation on Space Matters; US-Israel Cooperative Research and Development; US-Israel Defense Technology Cooperation Initiative; US-Israel Security Cooperation; US-Taiwan Security Cooperation; US-Ukraine Drone Working Groups; US-Ukraine EOD Partnership; US-Ukraine Military Trauma Education, Training, Research, and Medical Readiness Partnership; and US-Ukraine Security Cooperation). S. 4784, National Defense Authorization Act for Fiscal Year 2027, (issues related toAbraham Accords Defense Cooperation Initiative; AI Functional Bill of Materials; Analysis of Threats Posed by Foreign Adversary Access to Controlled Items Within the US; Assessment of Taiwans LNG Supply Chains; Assistance to LAF for Countering Hezbollah and Other Terrorist Groups; Audit and Mitigation of Covered Cellular Modules in the DOD Systems and Infrastructure; Briefing on Military and Intelligence Presence of Cuba in the Western Hemisphere; Chinese Cellular Modules; Codification of DOD Research Security Program; Countering Cartel Hydrocarbon Smuggling; Cybersecurity Training for Veterans and Military Spouses; Derived Sourcing Requirements for AI Outputs; DETERRENCE Act; DETERRENT Act; DLA Warstopper Program; DOD Economic Defense Unit; Expansion of Permissible Uses of Ukraine Support Fund; Extension and Modification of Pacific Deterrence Initiative; Extension of Report on Military Power of the PRC; Extension, Modification, and Redesignation of Taiwan Security Cooperation Initiative; Full Accountability for Chinese Military Companies; Inspector General for Foreign Assistance; Internal Base Hardening and Staged Internal Operations; Middle East IAMD Architecture; Modifications to Requirement for Public Reporting of Chinese Military Companies Operating in the US; Multiyear Procurement Authorities; PAID OFF Act; Plan on Remediation of Certain Equipment and Computational Facilities Owned or Controlled by a Foreign Adversary; PRC EMP Capabilities; Report on the Feasibility and Advisability of Establishing a Strategic Partnership on Defense Industrial Priorities between the US and Israel; Reports on Foreign Boycotts of Israel; REVOKE Act; Safeguarding DOD-Funded Research; SECURE Minerals Act; Securing Critical Weapons Systems Supply Chains; Securing US Military Mobility Infrastructure; Securing US Transportation Systems; Stop Foreign Spyware Act; Strategic Subsea Cables Act; Taiwan Energy Security and Embargo Act; Ukraine Drone Production and Strategy; US AI Policy; US Airport Cybersecurity Enhancements; US Critical Infrastructure Resilience Against EMP Weapons; US Cybersecurity Capabilities and Strategy; US Drone and Missile Defense Capabilities; US Healthcare Cybersecurity Enhancements; US Highways Cybersecurity Enhancements; US Indo-Pacific Policy and Strategy; US Maritime Cybersecurity Enhancements; US Rail Infrastructure Cybersecurity Enhancements; US Space Capabilities and Strategy; US-India Security Cooperation; US-Israel Defense Technology Cooperation Initiative; US-Israel Security Cooperation; US-Taiwan Security Cooperation; US-Ukraine Security Cooperation; and US-Ukraine Strategic Defense Innovation Working Group). Issues Related to Air Force Fighter Fleet Recapitalization; Chinas Military-Industrial Complex (CMIC); China-Iran-Russia Security Cooperation and Technology Development; Chinese Military Companies; Counter-Drone Technology Exchanges; Department of Defense Education Policy; Hardening U.S. Military Assets and Bases; Houthi Interdiction Efforts; Implementation and Oversight of the NDAA (FY23 - FY26); Irans Military Strategy and Capabilities; Irans Network of Terror Proxies; Iranian Weapons Proliferation; Operation Epic Fury; PRC Militarization and Surveillance Activities; Preserving Peace and Security in the Eastern Mediterranean; Russias Foreign Policy and Military Strategy; Safeguarding DOD-Funded Research; Securing DOD Supply Chains; U.S. Arms Sales and Procurement Strategies; U.S. CENTCOM Capabilities and Strategy; U.S. Counter-Robotics Strategy; U.S. Critical Mineral Policy and Diplomacy; U.S. DOD Post-Quantum Cryptography; U.S. Drone and Missile Defense Capabilities; U.S. F-35 Program; U.S. Indo-Pacific Strategy and Relations; U.S. Information Operations Capabilities and Strategy; U.S. International Legal Operations Strategy; U.S. Maritime Manufacturing Capacity; U.S. Military Posture in Europe; U.S. Military Posture in the Middle East; U.S. Nigeria Security Cooperation; U.S. Nuclear Deterrence Policy; U.S. Policy on Irans Ballistic Missile and Nuclear Programs; U.S. Policy on Irans Support for Terrorism; U.S. Policy on Russias War in Ukraine; U.S.-Iraq Security Cooperation; U.S.-Israel Security Cooperation; U.S.-Lebanon Security Cooperation; U.S.-NATO Security Cooperation; U.S.-Taiwan Security Cooperation; U.S.-Turkey Security Cooperation; U.S.-Ukraine Security Cooperation; and Ukraine Drone Production and Strategy (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145330,"prefix":"mr","prefix_display":"MR.","first_name":"NICHOLAS","nickname":"NICK","middle_name":null,"last_name":"STEWART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"H.R. 2658, Free Iraq from Iran Act, all provisions. H.R. 3307, Eastern Mediterranean Gateway Act, all provisions. H.R. 3563, Taiwan PLUS Act, all provisions. H.R. 36, MEGOBARI Act, all provisions. H.R. 4531, BANNED in Latin America Act, all provisions. H.R. 6230, Tehran Incitement to Violence Act, all provisions. H.R. 6469, Feasibility Review of Emerging Equipment for Digital Open Media (FREEDOM) Act, all provisions. H.R. 7380, Internet Reach and Access Now (IRAN) Act, all provisions. H.R. 7567, Farm, Food, and National Security Act of 2026 (issues related to Binational Agricultural Research and Development; CFIUS Consideration of Certain Agricultural Land Transactions; and Rural Water and Wastewater Circuit Rider Program). H.R. 7622, Iran Human Rights, Internet Freedom, and Accountability Act of 2026, all provisions. H.R. 7668, Countering Chinas Control of the Caucasus Act, all provisions. H.R. 8433, Countering Russias War on Faith Act, all provisions. H.R. 8595, National Security, Department of State, and Related Programs Appropriations Act, 2027, (issues related to International Narcotics and Law Enforcement; Democracy Programs in Latin America; and Assistance to South Africa). H.R. 8693, Deter PRC Aggression Against Taiwan Act, all provisions. H.R. 8700, Protecting U.S. Farmland and Sensitive Sites from Foreign Adversaries Act, all provisions. H.R. 8718, Countering Russias Forced Recruitment and Kidnapping in Africa Act, all provisions. H.R. 9020, No U.S. Funding for UNIFIL Act, all provisions. H.R. 9087, To direct the Secretary of State to take actions with respect to certain foreign affairs matters, (issues related to Baltic Regional Security; Gaza Health Ministry; Certification Requirement for Major Arms Sales to Turkey; IGO Anti-Boycott Act; and BANNED in Latin America Act). H.R. 9147, Abraham Accords Expansion Act of 2026, all provisions. H.R. 9450, Countering Russian Trafficking Act, all provisions. H.Res. 1379, Condemning Lebanese Hezbollahs repeated violations of ceasefire agreements and calling for the Lebanese Government to ensure Lebanese Hezbollah immediately ceases all attacks and disarms, in accordance with the ceasefire, all provisions. S. 1824, Taiwan PLUS Act, all provisions. S. 3360, Feasibility Review of Emerging Equipment for Digital Open Media (FREEDOM) Act, all provisions. S. 3496, United States Legal Gold and Mining Partnership Act, all provisions. S. 3900, Iran Human Rights, Internet Freedom, and Accountability Act of 2026, all provisions. S. 4192, Property Location Oversight and Transparency (PLOT) Act of 2026, all provisions. S. 4296, IGO Anti-Boycott Act, all provisions. S. 4379, Countering Russias War on Faith Act, all provisions. S. 4392, Energy Security Pacts Act, all provisions. S. 4600, South China Sea Strategy Act of 2026, all provisions. S. 4665, BANNED in Latin America Act, all provisions. S. 4853, United States-Israel Agriculture Cooperation Improvement and Expansion Act, all provisions. H.R. 8800, National Defense Authorization Act for Fiscal Year 2027, (issues related to Abraham Accords Central Asia Expansion Act; Abaraham Accords Authorities Expansion; Accountability for Terrorist Perpetrators of October 7th Act; Arms Delivery Queue Report; Arms Sales and Weapons System Transfers to NATO countries; Authorization of Activities to Counter Russia; BANNED in Latin America Act; Business in the Balkans; Captagon, Fentanyl, and International Narcotics Production and Trafficking; Certification Requirement for Major Arms Sales to Turkey; Closing Loopholes in Russia Sanctions; Countering Russias War on Faith Act; Deployment of a Financial Attache to the US Embassy in Jerusalem; Deterring Adversary Ill-Gotten Gains Act; AI OVERWATCH Act; American Space Leadership for the 21st Century Act; BIS License Administration Enhancement Act; BIS STRENGTH Act; Block the Use of Transatlantic Technology in Iranian Made Drones Act; China AI Power Report Act; Chip Security Act; Countering Chinas Control of the Caucasus; Countering Russias Forced Recruitment and Kidnapping in Africa Act; Deterring American AI Model Theft Act; Dismantle Foreign Scam Syndicates Act; Developing Overseas Mineral Investments and New Allied Networks for Critical Energies (DOMINANCE) Act; Decreasing Russia Oil Profits (DROP) Act; ECRA Penalty Increase Act; ECRA Statute of Limitations Extension; Enhanced Iran Sanctions Act; Export Control Enforcement and Enhancement Act; Export Controls Enforcement Act; Foreign Adversary AI Risk Assessment and Diplomacy Act; Feasibility Review of Emerging Equipment for Digital Open Media (FREEDOM) Act; Full AI Stack Export Promotion Act; Interagency Coordination in Export Controls Act; Interagency Strategy to Disrupt and Dismantle Narcotics Production and Trafficking and Affiliated Networks Linked to the Regime of Bashar al-Assad in Syria; ITAR Licensing Reform Act; Kleptocracy Asset Recovery Rewards Program Act; Limitation on Contributions to the UN; Limitation on Transfer of Weapons to Turkey; Limitation Regarding Certain Export Controls; Multilateral Alignment of Technology Controls on Hardware (MATCH) Act; MEGOBARI Act; No US Funding for UNIFIL Act; No Official Palestine Entry (NOPE) Act; Participation of Russia in the G7; Preventing the Escalation of Armed Conflict in Europe (PEACE) Act; Peace Through Strength Act; Polisario Front Terrorist Designation Act; Preventing Rogue Equipment for Synthetic Substances (PRESS) Act; Prohibition on Delay of Arms Sales to Taiwan; Remote Access Security Act; REPO Implementation Act; Report on Allied Information Sharing to Counter Foreign Malign Influence; Report on Backlog of FMS to Taiwan; Russia-North Korea Cooperation Sanctions Act; Sanctions List Harmonization Act; Strategic Hybrid Activities Defense and Operations for the West (SHADOW) Act; STOP HATE Act; Stop Stealing Our Chips Act; Strategic Dialogue to Return Democratic Rule to Belarus; Strategic Subsea Cables Act; Streamlining Foreign Military Sales Act; Semiconductor Technology Resilience, Integrity, and Defense Enhancement (STRIDE) Act; Taiwan Allies Fund Act; Taiwan Energy Security and Anti-Embargo Act; Taiwan PLUS Act; US Arms Sales and Procurement Strategies; US Iran Sanctions Policy; US Support for the Iranian People; War Reserve Stockpiles for Allies; and XPCC Sanctions Act). S. 4784, National Defense Authorization Act for Fiscal Year 2027, (issues related to BANNED in Latin America Act; BIS License Administration Enhancement Act; BIS STRENGTH Act; China AI Power Report Act; Chip Security Act; Countering Chinas Control of the Caucuses Act; Critical Undersea Infrastructure Resilience Initiative Act; Deterring American AI Model Theft Act; Eastern Mediterranean Gateway Act; ECRA Statute of Limitations Extension Act; Eliminate PRC Organized Crime Act; FREEDOM Act; Imposition of Sanctions with Respect to Trade in Russian Origin Petroleum Products; Iran Human Rights, Internet Freedom, and Accountability Act; MATCH Act; MEGOBARI Act; No Hezbollah In Our Hemisphere Act; PORCUPINE Act; Religious Infrastructure in Ukraine; Remote Access Security Act; REPO Implementation Act; Sense of Congress on Illegal Abduction of Ukrainian Children by Russia; SHADOW Fleet Sanctions Act; Statement of Policy on Repeal of Sunset of Iran Sanctions Act of 1996; US Iran Sanctions Policy; US Legal Gold and Mining Partnership Act; US Russia Oil Waivers and Sanctions Policy; US Sanctions Authorities, Implementation, Enforcement, Resourcing, and Policy; US South Africa Bilateral Relations Review Act; and War Reserve Stockpiles for Allies). Issues related to Abraham Accords Authorities; AGOA Reauthorization; Chinas Foreign Policy and Military Strategy; Chinese and Russian Activities in Africa; Chinese Investments in the Middle East; Chinese, Iranian, and Russian Activities in Latin America; Congressional Oversight of U.S. Arms Sales; Congressional Oversight of U.S. Foreign Assistance; Implementation and Oversight of Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Implementation and Oversight of Consolidated Appropriations Act, 2026; Implementation and Oversight of Continuing Appropriations, Agriculture, Legislative Branch, Military Construction, and Veterans Affairs, and Extension Act, 2026; Implementation and Oversight of the Iran Nuclear Agreement Review Act; Implementation and Oversight of the National Security Act of 2024; Israel-Syria Relations; Normalization in the Middle East; Protecting International Religious Freedom; Qatars, South Africas, and Turkeys Support of Terrorism; Russias Mass Abduction of Ukrainian Children; Strengthening the National Endowment for Democracy; Support for U.S. Allies at International Organizations; Syria-Turkey Relations; U.S. Contributions to and Oversight of International Organizations; U.S. Energy Security Policy; U.S. Foreign Affairs-Related Appropriations; U.S. Foreign Aid Policy and Reform; U.S. International Development Finance Corporation; U.S. Policy on Chinas Human Rights Abuses and Repression; U.S. Policy on Irans Human Rights Abuses and Censorship; U.S. Support for the Iranian People; U.S. Victims of Terrorism; U.S. Western Balkans Strategy; U.S.-Cuba Policy and Relations; U.S.-Honduras Policy and Relations; U.S.-Iran MOU and Negotiations; U.S.-Iraq Relations; U.S.-Latin America Foreign Policy and Strategy; U.S.-Mexico Policy and Relations; U.S.-Nicaragua Policy and Relations; U.S.-Qatar Policy and Relations; U.S.-South Africa Policy and Relations; U.S.-South Korea Policy and Relations; U.S.-Turkey Policy and Relations; U.S.-Venezuela Energy Policy; U.S.-Venezuela Policy and Relations (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145330,"prefix":"mr","prefix_display":"MR.","first_name":"NICHOLAS","nickname":"NICK","middle_name":null,"last_name":"STEWART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"H.R. 1736, Generative AI Terrorism Risk Assessment Act, all provisions. H.R. 2158, Countering Transnational Repression Act of 2025, all provisions. H.R. 2212, DHS Intelligence Rotational Assignment Program and Law Enforcement Support Act, all provisions. H.R. 3463, Comprehensive Operations for Unmanned-System Neutralization and Threat Elimination Response (COUNTER) Act, all provisions. H.R. 6105, Restricting Ex-Vetted Officials from Knowledge Exploitation (REVOKE) Act, all provisions. H.R. 6106, Conflict-free Leaving Employment and Activity Restrictions (CLEAR) Path Act, all provisions. H.R. 6107, Preventing Adversary Influence, Disinformation, and Obscured Foreign Financing (PAID OFF) Act of 2025, all provisions. H.R. 8022, DETECT Nitazenes Act of 2026, all provisions. H.R. 881, DHS Restrictions on Confucius Institutes and Chinese Entities of Concern Act, all provisions. S. 2132, CLEAR Path Act, all provisions. S. 3050, Preventing Adversary Influence, Disinformation, and Obscured Foreign Financing (PAID OFF) Act of 2025, all provisions. S. 3181, REVOKE Act, all provisions. Issues related to Foreign Threats to U.S. Homeland (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"H.R. 4142, No Adversarial AI Act, all provisions. H.R. 6309, Cyber Deterrence and Response Act of 2025, all provisions. H.R. 7037, Developing Overseas Mineral Investments and New Allied Networks for Critical Energies (DOMINANCE) Act, all provisions. H.R. 7625, Marine Transportation System Cybersecurity Budget and Evaluation Report (MTS CYBER) Act of 2026, all provisions. H.R. 7924, Trucking Security and CCP Disclosure Act of 2026, all provisions. H.R. 8516, American Leadership in AI Act, all provisions. H.R. 8558, Defending American Research Act, all provisions. H.R. 8730, Connected Vehicle Security Act of 2026, all provisions. H.R. 9102, Biotech Investment National Security Act (BINSA), all provisions. H.R. 9129, Guarding the U.S. Against Adversarial Robotics Dominance (GUARD) Act of 2026, all provisions. H.R. 9227, Magnets Value Chain Support Act of 2026, all provisions. H.R. 9592, American Space Leadership in the 21st Century Act, all provisions. S. 4429, Connected Vehicle Security Act of 2026, all provisions. S. 4525, Securing Innovation and Research from Adversaries Act, all provisions. S. 4565, Strengthening Cyber Resilience Against State-Sponsored Threats Act, all provisions. S. 4570, U.S. Tech Path Act, all provisions. Issues Related to Chinese Biotech Industry and Dual-Use Threats; Chinese Cellular Modules; Chinese EV Manufacturing; Chinese Robotics Capabilities and Strategy; Chinese Unmanned Aerial Systems; Chinese, Iranian, and Russian Cyber Operations; Chinese-Made Battery Storage Systems; CISA Resourcing; Cyber-Informed Engineering; Cybersecurity Capabilities of U.S. Allies; Development of Internet Access Technologies; Information Technology Devices from Foreign Adversary-Controlled Companies; Light Detection and Ranging Sensor Technology; National Guard Role in Cyber Incident Response; Securing Critical U.S. Infrastructure and Mineral Supply Chains; Securing U.S. Defense Technology; Securing U.S. Military Mobility Infrastructure; Securing U.S. Transportation Systems; U.S. Adversarial Use of AI and Quantum Technology; U.S. AI Chip Security; U.S. Airport Cybersecurity Enhancements; U.S. Artificial Intelligence Policy; U.S. Cybersecurity Capabilities and Strategy; U.S. Data Security Capabilities and Strategy; U.S. Drone Production and Market Security; U.S. Emerging Technology Capabilities, Development, and Strategy; U.S. Fusion Energy Development; U.S. Healthcare Cybersecurity Enhancements; U.S. Highways Cybersecurity Enhancements; U.S. Maritime Cybersecurity Enhancements; U.S. Nuclear Energy Capabilities; U.S. Quantum Technology Capabilities; U.S. Rail Infrastructure Cybersecurity Enhancements; U.S. Space Capabilities and Strategy (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 1048, Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act, all provisions. H.R. 8559, No Branch Campuses in Hostile Countries Act, all provisions. H.R. 8901, Securing Innovation and Research from Adversaries Act, all provisions. S. 1296, Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act, all provisions. S. 4423, Defending American Research Act, all provisions. S. 4424, No Branch Campuses in Hostile Countries Act, all provisions. Issues related to Foreign Gift Compliance Transparency; Foreign Influence in Nonprofit Sector; Foreign Influence in U.S. Higher and Elementary Education; and Securing American Funding and Expertise from Adversarial Research Exploitation (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"H.R. 6988, Trade Transparency Unit Strategy Act, all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cf45130f-a434-47e4-aecc-79818a163ea1/","filing_uuid":"cf45130f-a434-47e4-aecc-79818a163ea1","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cf45130f-a434-47e4-aecc-79818a163ea1/print/","filing_document_content_type":"text/html","income":null,"expenses":"750000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Melissa Banashak","dt_posted":"2026-07-20T14:01:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1801 Augustine Cut-Off","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Wilmington","registrant_state":"DE","registrant_zip":"19803","registrant":{"id":401105844,"url":"https://lda.gov/api/v1/registrants/401105844/","house_registrant_id":null,"name":"INCYTE CORPORATION","description":"Biopharmaceutical Company","address_1":"1801 Augustine Cut-Off","address_2":null,"address_3":null,"address_4":null,"city":"Wilmington","state":"DE","state_display":"Delaware","zip":"19803","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MELISSA BANASHAK","contact_telephone":"+1 202-379-8022","dt_updated":"2026-07-28T17:00:17.422432-04:00"},"client":{"id":207939,"url":"https://lda.gov/api/v1/clients/207939/","client_id":12,"name":"INCYTE CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DE","state_display":"Delaware","country":"US","country_display":"United States of America","ppb_state":"DE","ppb_state_display":"Delaware","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 946 / S. 1862, Orphan Cures Act implementation H. Res. 1331, Expressing support for \"Hidradenitis Suppurativa Awareness Week\" S. 2658, Medication Affordability and Patent Integrity Act Issues related to Medicaid rebates Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140710,"prefix":"ms","prefix_display":"MS.","first_name":"MELISSA","nickname":null,"middle_name":"WIER","last_name":"BANASHAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148415,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"BARBLAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d7c45bae-3ef1-4a39-b77b-6192d65049d9/","filing_uuid":"d7c45bae-3ef1-4a39-b77b-6192d65049d9","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d7c45bae-3ef1-4a39-b77b-6192d65049d9/print/","filing_document_content_type":"text/html","income":null,"expenses":"45000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Karen Kerrigan","dt_posted":"2026-07-20T14:24:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"200 Lawyers Road NW #1506","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Vienna","registrant_state":"VA","registrant_zip":"22183","registrant":{"id":35627,"url":"https://lda.gov/api/v1/registrants/35627/","house_registrant_id":32706,"name":"SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL)","description":null,"address_1":"301 Maple Avenue, West","address_2":"Suite 609","address_3":null,"address_4":null,"city":"Vienna","state":"VA","state_display":"Virginia","zip":"22180","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KAREN KERRIGAN","contact_telephone":"+1 703-242-5840","dt_updated":"2026-10-20T10:09:40.747437-04:00"},"client":{"id":144095,"url":"https://lda.gov/api/v1/clients/144095/","client_id":12,"name":"SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"GOOD GOVERNMENT: White House Conference on Small Business Act, H.R. 6855: Support action by U.S. House to advance the legislation. DME Scammer Prevention Act of 2026, H.R. 8871: Support the legislation. Preventing Waste, Fraud and Abuse in TANF Act, H.R. 8872: Support the legislation. Protecting Seniors and Stopping Fraudsters Act, H.R. 8883: Support the legislation. Recover COVID Unemployment Fraud in Banks Act, H.R. 8873: Support the legislation. Supporting Rural Communities, H. Res. 1182: Supported House passage of the resolution. WORKFORCE ISSUES: Workforce Apprenticeship Growth and Education Support (WAGES) Act, H.R. 8624 and S. 4463: Support the legislation. Faster Labor Contracts Act, H.R. 5408: Opposed House passage of the legislation. Flexibility for Workers Education Act, H.R. 2262: Continue to support U.S. House passage of the bill. Empowering Employer Child and Elder Care Solutions Act, H.R. 2270: Continue to support U.S. House passage of the bill. Working Families Flexibility Act, H.R. 2870: Continue to support U.S. House passage of the bill. Tipped Employee Protection Act, H.R. 2312: Support U.S. House passage of the bill. DOLs Proposal to Expand Investment Opportunities in 401(k) Plans (Fiduciary Duties in Selecting Designated Investment Alternatives): Expressed support for a proposed rulemaking to provide American workers, small business owners and their employees with access to the same diversified opportunities long available to large pension funds. Submitted Comments to Department of Labor (DOL) on Employee or Independent Contractor Status Under the Fair Labor Standards Act, Family and Medical Leave Act, and Migrant and Seasonal Agricultural Worker Protection Act: Expressed support for the proposed rule changes on independent contractors. President Trumps Executive Order on PROMOTING RETIREMENT-SAVINGS ACCESS FOR AMERICAN WORKERS BY ESTABLISHING TRUMPIRA.GOV: Expressed support for the initiative. ACCESS TO CAPITAL: INVEST Act, H.R. 3383: Support U.S. Senate passage of this Housed-passed bill. Submitted Comments to the Federal Reserve on Regulatory Capital Rule: Category I and II Banking Organizations, Banking Organizations with Significant Trading Activity, and Optional Adoption for Other Banking Organizations [R-1887]: SBE Council welcomed the re-proposal as a substantive improvement over the 2023 version and made slight recommendations. Submitted Comments to the Office of the Comptroller (OCC) on National Bank Non-Interest Charges and Fees, and interim final order, Order Preempting the Illinois Interchange Fee Prohibition Act. SBE Council expressed support for these actions. TAX POLICY: Small Business Tax Cut Act, H.R. 8415: Support the legislation. Indexing Capital Gains Tax Liability to Inflation: Support legislative or administrative action to make this change. H. Res. 1156 which Expresses Support for Tax Policies that Support Working Families: Supported the House resolution. More Homes on the Market Act, H.R. 1340, S.3332: Support the legislation. American Innovation Act, H.R. 1778, S. 4207: Support the legislation. BUSINESS STARTUP AND GROWTH: SAVE Local Businesses Act, H.R. 4366: Support U.S. House passage of the bill. New Opportunities for Business Ownership and Self-Sufficiency Act (NO BOSS Act), H.R. 6431: Supported U.S. House passage of the legislation. American Innovation Act, H.R. 1778, S. 4207: Support the legislation. Submitted Comments to Federal Trade Commission and Department of Justice on Making Improvements to the Premerger Notification and Report Form: Urged the agencies to consider maintaining the current HSR form and system, as potential changes have not been substantiated with failures, problems or flaws. AI AND TECHNOLOGY Continue to voice restraint on excessive regulatory frameworks or actions that would undermine what is a critical new technology for small businesses. SECURE Data Act (Securing and Establishing Consumer Uniform Rights and Enforcement over Data Act), H.R. 8413: Welcomed the introduction of comprehensive data privacy legislation. AI Education: Continue to brief congressional staff on the benefits of AI to small businesses and startups as conveyed through SBE Council research and surveys. American Innovation and Choice Online Act (AICOA). S. 4746: Oppose the legislation. REGULATORY REFORM AND MODERNIZATION Guidance Out of Darkness (GOOD) Act (H.R. 1515): Urged Senate to advance House-passed bill. Information Quality Assurance Act (H.R. 6329): Urged Senate to advance House-passed bill. ESA Amendments Act, H.R. 1897: Supported House passage of the bill. Prove It Act of 2025, H.R. 1163: Support House action and passage of the bill. 21st Century ROAD to Housing Act, H.R. 6644: Supported House amendment to the Senate-passed bill and final bill that went into law. Reducing and Eliminating Duplicative Environmental Regulations (RED Tape) Act, H.R. 6398: Supported House passage of the legislation. Earnings Claims Rulemaking and Business Opportunity Rule: Continue to express concerns about these Biden-Era regulatory efforts that remain on the Federal Trade Commissions regulatory agenda Standardizing Permitting and Expediting Economic Development Act (SPEED Act), H.R. 4776: Supporting Senate action on House-passed bill. Promoting Efficient Review for Modern Infrastructure Today (PERMIT) Act, H.R. 3898: Support Senate action on House-passed bill. Repealing Big Brother Overreach Act, H.R. 425: Support the legislation. GOVERNMENT REFORM AND OPERATIONS: Tax Relief for Fraud Victims Act, H.R. 9500: Support the legislation. AI Tax Integrity Act of 2026, H.R. 9501: Support the legislation. Taxpayer Advocate Participation Act, H.R. 9498: Support the legislation. Taxpayer Assistance and Service Act. S. 3931: Support the legislation. Taxpayer Due Process Enhancement Act, H.R. 6506: Support U.S. Senate action on the House-passed bill. Taxpayer Notification and Privacy Act, H.R. 6495: Support U.S. Senate action on the House-passed bill. HEALTHCARE AND AFFORDABLE HEALTH COVERAGE: HSAs For All Act, H.R. 7681: Support the legislation. Lower Health Care Premiums for All Americans Act, H.R. 6703: Support Senate action of House-passed bill. 340B Drug Program: Continue to voice concerns about this program to Congress (in terms of effects on high drug and health premium costs) and the need for reforms. Medication Affordability and Patent Integrity Act, S. 2658: Expressed concern about the legislation. Biosimilar Red Tape Elimination Act, S. 1954: Expressed concern about the legislation. Ensuring Timely Access to Generics Act, S. 3014: Expressed concern about the legislation. Abolish the Center for Medicare and Medicaid Innovation (CMMI) Act, H.R. 8293: Support the legislation. TRADE AND GLOBAL MARKET ACCESS: Submitted coalition comments to U.S. Department of Commerce on Section 232 Investigation of Imports of Semiconductors and Semiconductor Manufacturing Equipment (91 FR 2443): Urged the Administration to refrain from imposing tariffs on semiconductors and downstream consumer and commercial technology products.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":15722,"prefix":null,"prefix_display":null,"first_name":"KAREN","nickname":null,"middle_name":null,"last_name":"KERRIGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":21795,"prefix":null,"prefix_display":null,"first_name":"RAYMOND","nickname":null,"middle_name":null,"last_name":"KEATING","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":62,"name":"Federal Reserve System"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":183,"name":"Office of the Comptroller of the Currency (OCC)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/956076c6-86a3-42ed-bf18-8375d3295b7b/","filing_uuid":"956076c6-86a3-42ed-bf18-8375d3295b7b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/956076c6-86a3-42ed-bf18-8375d3295b7b/print/","filing_document_content_type":"text/html","income":null,"expenses":"7360000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-07-20T15:46:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S.___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S.___: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S.___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Presidents Budget Fiscal Year 2027 Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act H.R. 9661: Expedited Access to Biosimilars Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 6089: Biomanufacturing Excellence Act of 2025 H.R. 9102: Biotech Investment National Security Act of 2026 (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/956076c6-86a3-42ed-bf18-8375d3295b7b/","filing_uuid":"956076c6-86a3-42ed-bf18-8375d3295b7b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/956076c6-86a3-42ed-bf18-8375d3295b7b/print/","filing_document_content_type":"text/html","income":null,"expenses":"7360000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-07-20T15:46:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S.___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S.___: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S.___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Presidents Budget Fiscal Year 2027 Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act H.R. 9661: Expedited Access to Biosimilars Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 6089: Biomanufacturing Excellence Act of 2025 H.R. 9102: Biotech Investment National Security Act of 2026 (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}